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TERTIARY CARE CENTRE AND CONFIRMATION BY QUANTITATIVE  
BACTERIOLOGICAL  ASSAY 
 
Aim and Objectives: 
 Wound sepsis seems to be the most important and life threatening 
complications of all burned patients. Evaluation of the burns wound by a surface 
swabbing has been the principle method in my institution till date. This study 
emphasizes a method of quantitative bacterial count by a tissue biopsy technique 
for a more accurate method of assessing the burn wounds. Surface swabbing gives 
surface colonization,while a count >105  CFU/gm of tissue in the quantitative assay 
were likely to develop sepsis and also to predict graft bed receptiveness and safety 
of wound closure. 
 
Materials and methods: 
83surface swabs and 209 tissue biopsy specimens were collected from a total 
number of 83 patients. Biopsy was taken with a help of  No.11 blade  and Alley”s 
forceps. Then it was weighed and  homogenized in a Lab Blender Stomacher 80. 
Four fold dilutions of the homogenate was made. Then they were inoculated in 
MacConkey and Blood agar plates and after 24 hours incubation colonies counted 
by formula. 
 
 
Results and Observations: 
 Out of 83 patients, 54.22% were females and 45.78% were males.The most 
common age group affected was 16-30 years (51.81% )and 31.33% acquired 10-
20% TBSA burns.61.45% were surface swab culture positive and 95.22% were 
tissue biopsy culture positive. More number of CoNS(14.13%), 
Micrococci(7.61%), Diphtheroids(2.17%)and culture negatives(15.22%) were 
reported in swab cultures but not in tissue cultures.Staphylococcus was the 
predominant organism isolated.Bacterial counts for the organisms ranged from 
0.54 to 4.40 x 105 per gram of tissue. Bacterial counts < 105 yielded a graft take of 
95-100%, while counts >105 yielded a graft take of 60%. 
 
Conclusion: 
 Superficial  swabbing is a simple, inexpensive and convenient method, but 
does not  reflect the exact pathogen status,while quantitative bacteriology is also 
simple by the above method and provides an exact count of bacteria and provides 
most reliable data in predicting burn wound sepsis. This should be employed in 
every public and private burn care units  to reduce burn related deaths. 
 
Key words: Surface swabbing, tissue biopsy culture, quantitative assay, 
homogenization. 
                  
                                              
INTRODUCTION 
 
 
INTRODUCTION 
Burns are one of the most common and devastating forms of 
trauma. Patients with serious thermal injury require immediate 
specialized care in order to minimize morbidity and mortality. Infection 
causes 50% to 60% of deaths in burn patients in spite of intensive therapy 
with antibiotics both topical as well as intravenous1. Burn wounds are 
highly susceptible to colonization and infection and this is the major 
problem in the management of burn victims. Initially, the burnt area is 
considered free of microbial contamination. Major burn wounds usually 
become infected within 3-5 days after admission, so it is obvious that the 
infection arises from the patient’s own bacterial flora and is not an 
exogenous occurrence.2 
In order to promote infection control in a burn patient, burn 
wounds should be recognized at sites of microbial colonization which 
may progress to invasion which leads to systemic dissemination, if not 
prevented. Colonization arises from the patient’s own resident and 
transient flora.3,4,5,6,7 Bacteria which are not normally recovered from the 
skin surface and sweat glands may be identified in the hair follicles 
particularly near the orifices of sebaceous glands. Those on the surface 
are heat killed, so that the initial swab cultures are usually sterile. But 
gram-positive bacteria found in the depth of sweat glands and hair 
follicles heavily colonize the wounds within 48 hours of the injury and 
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therefore survive, and quantitative counts of the biopsied specimen show 
the same 103 bacteria per gram of tissue, as found in the tissue prior to 
burning8. As the bacteria proliferates following burn injury and reach 
levels of greater than 105 bacteria per gram of tissue, they will break out 
of the hair follicles and glands and begin to migrate through the tissue, 
colonizing along the dermal sub-dermal interface9.Perivascular growth is 
accompanied by thrombosis of vessels, necrosis of any remaining dermal 
elements, converting partial thickness burn to full thickness burn 
injuries.10 
The subeschar tissue is the site where bacterial proliferation takes 
place. When the level of bacterial growth exceeds 106 or 107 , then 
microbial invasion into the bloodstream occurs. This is the most 
important cause, leading to septicaemia.11 
Multiple studies from the United States Army Institute of Surgical 
Research (USAISR) made invasive burn sepsis synonymous with a 
bacteria count of 105 or greater than105 bacteria per gram of tissue. So 
monitoring the bacterial load has become an important tool in predicting 
and preventing invasive burn wound sepsis.12,13,14 
Various modalities have been employed in monitoring sepsis in 
burn patients. It has been observed that a rapid Gram stain can reliably 
predict a microbial load of 105 CFU/gm of tissue if a single 
microorganism has been seen on a slide preparation15,16. Some studies 
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were done prioritizing histopathology over all other methods as it 
demonstrates true invasion.17 This histopathological evalution can detect 
bacteria, fungus by Periodic acid-Schiff  (PAS) and Gomori’s 
methenamine silver (GMS), although cultures must be obtained to 
definitively identify and give sensitivity of the pathogen. Another 
technique which has been utilized is the velvet pad surface imprint 
technique. Dermabrasion as a sampling method has also been used.18 
Wound fluid sampling can also be done when copious volume of burn 
wound fluid exists, sampling by needle aspiration is employed. This is 
superior to swabbing and it requires strict aseptic precautions so that 
samples can be retrieved without any significant exogenous 
contamination.18An alginate-tipped swab can be used to perform a full 
quantitative analysis, since the swab will dissolve and release all 
associated microorganisms when transferred to an appropriate diluent. 
Despite its widespread use, there is debate over the value of the swab 
sampling technique and the value of cleansing a wound before swabbing 
is performed. A variety of other techniques, including the dry and 
presoaked velvet pad, filter paper disks and cylinder scrubbing, have also 
been used to sample superficial wound fluid for microbiological analysis. 
The immense number of sampling methods available creates a problem 
since all are reputed to have benefits and there is no single, universally 
accepted method. Thus the debate and controversy continues regarding 
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the type of sample required to provide the most meaningful data.19,20,21 
The three  most popular methods are surface swabbing  by cotton tipped 
swabs, blood cultures and quantitative bacterial assay by deep tissue 
biopsy techniques. The value of superficial cultures in wound assessment 
has been questioned and it is stated that purulent wound fluid may fail to 
yield growth whereas biopsied tissue may yield significant numbers of 
bacteria.22 Swab sampling has been challenged on the basis that the 
superficial colonizers do not reflect the organisms of deeper tissue and 
that subsequent cultures do not correlate with the presence of pathogenic 
bacteria.21 But the procedure of superficial swab samples is simple, 
inexpensive, non-invasive and convenient for the majority of wounds. On 
the other hand, blood cultures yield a positive culture report only at a later 
date even when the organisms are present . Tissue biopsy is the gold 
standard for microbial conclusive evidence. This method is most 
beneficial in determining the optimal time for skin grafting and surgical 
wound closure.23 However, the value of a single biopsy specimen 
particularly in slow healing chronic wounds is debatable. So multiple 
specimens are taken for a more accurate diagnosis.  
Bacteriological assessment is done on: 
 The day of admission, as it is important to know the 
bacteriological  status at the commencement of treatment.  
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 On the third or fourth day, when the period of maximum 
exudation is over to assess the bacterial colonization 
 Twice weekly as there is an indication, according to clinical signs 
 Three days before any proposed grafting procedure. So that 
the results are available before making a final decision about the 
surgery.24 
So the main aim for any strategy dealing with burn wounds should 
have definite goals in achieving an effective infection control .The goals 
should be to prevent transmission of exogenous organisms to patients or 
personnel, to control the transmission of endogenous organism, that is, 
the normal flora to sites at increased risk of infection and to protect and 
support existing defenses in patients with seriously impaired resistance. 
This study focusses on aspects of history, pathophysiology, microbial 
etiology and microbial analysis of burn wound infection with special 
emphasize laid on the surveillance of burn wound infections and its 
culturing techniques. This study is also aimed at providing preventive 
measures of burn wound infections and reviewed in the context of 
infection control by a combination of many procedures such as aseptic 
precautions, surgical intervention at appropriate time, culturing methods, 
therapeutic strategies, environmental control and strict adherence to 
recommended policies and procedures by the entire burn care team.  
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Surface wound swabs are currently used in many centres in India 
do not give  the exact count of pathogens involved in burn wound sepsis; 
they throw light on results at times.25,26 Therefore in order to monitor 
burn wound, quantitative bacteriology is essential and there should be a 
technique for monitoring bacterial counts. Wound sepsis seems to be the 
most important and life threatening complications of all burned patients. 
Evaluation of the burns wound by a surface swabbing has been the 
principle method in my institution till date. This study emphasizes a 
method of quantitative bacterial count by a tissue biopsy technique for a 
more accurate method of assessing the burn wounds. Surface swabbing 
gives surface colonization and may not accurately reflect the organism 
causing wound infection while a count of 105  CFU/gm of tissue in the 
quantitative assay were likely to develop sepsis and also to predict graft 
bed receptiveness and safety of wound closure 
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AIM AND OBJECTIVES 
 
 
AIM 
 To emphasize a method of quantitative bacterial  assay  by  tissue 
biopsy technique for  accurate microbial  assessment of  burn wound  
infections.  
OBJECTIVES 
1. To study the bacteriological profile of burn wound infections in 
Thanjavur Medical College Hospital. 
2. To do Quantitative Bacterial Assay in burn wound infections 
3. To study the antimicrobial susceptibility pattern of the organisms 
isolated.  
4. To study the resistance pattern of the organisms isolated from the 
burn wounds. 
5. To emphasize the importance of quantitative bacterial assay to 
provide clinical guidelines for reconstructive procedures. 
6. To assess the clinical outcome of patients who underwent 
reconstructive  procedures following guidance of quantitative 
bacterial assay. 
7. To predict sepsis by this method and thus aiding its prevention. 
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REVIEW OF LITERATURE 
 
 
HISTORICAL REVIEW 
 Since the discovery of the first flame, the exothermic combustion 
reaction of oxygen and carbon have exposed human flesh to significant 
destruction and disfigurement in the form of burns.27  The history of the 
treatment of burn injuries and burn care has slowly evolved as a rational 
treatment process from ages unknown. Table 1 shows the history of 
treatment of burns since man had evolved.28 
Table 1 - Burn treatment history 
Neanderthal man Extracts of plants 
Smith papyrus (1500 BC) 
Egyptians 
Gum and goat’s milk mixed with 
mother’s milk, strips soaked in oil 
Chinese (600-500 BC) Extracts of tea leaves 
Hippocrates (430 BC) Swines semen, resin, and bitumen 
Oak bark solutions 
Celsus (ancient Rome) Honey and bran 
Galen (ancient Rome) Vinegar and wine 
Rhases (9th century) Cold water 
Pare (1517 – 1596) Excision and ointments 
David Cleghorn (1792) 
 
Vinegar and chalk poultice 
Edward Kentish (1797) Pressure dressings 
Syme (1827) Wool dressings 
Lisfranc (1835) Calcium chloride dressings 
Passavant (1858) Saline dressings 
Tomasalis (1897) Salt water injections 
 
 From Salisbury RE:Thermal burns. In McCarthy JM, ed:Plastic 
Surgery, Philadelphia, WB Saunders, 1990:788 
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In 16th century Ambrose Pare, a 
French Surgeon practiced burn wound 
care for the war victims. He was called 
as the Father of modern Surgery. He 
used invasive emollient Salves and 
compression dressings for burn 
wounds.29 He also altered the 
discipline of Surgery and approach to 
burn wounds. In 18th century John Hunter a Scottish Surgeon worked on 
Burns Surgery30. In 19th century Dr. Jacob Bigelow an Harvard Physician 
practiced evidence based medicine in burn care. He conducted control 
studies  in rabbits by adding a stimulant such as turpentine versus 
immersing burns in vat of ice water. His results were published in the first 
journal of The New England Journal of Medicine, Surgery and Collateral 
Branches of Science.31       
Dr. Dominique Jean Larry, 
King Napoleon’s chief 
Surgeon found out effective 
treatment of burns by a wax 
based paste known as cerate 
to cover burns. Also found ″flying ambulance″ consisting of 113 men 
 DR.AMBROSE PARE 
FLYING AMBULANCE 
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DR.DOMINIQUE LARRY’S FLYING AMBULANCE 
 
 
with 12 light and 4 heavy transport carriages to carry burn patients to 
central medical port.32 
Dr. Guillaume Dupuytren called as Father of modern Plastic 
Surgery.33,34 He was the first person to describe the                                                                 
pressure lines and termed  them as ″contractures” and also found 
treatment for it. He also showed that debridement of dead tissue and 
application of silver nitrate, emollients and 
cerate along with compression dressings 
improved burn wounds. The combination 
of all this reduced the chance of infection, 
promoted healing and improvement of 
rehabilitation.35,36,37 Variation of these 
treatments remain in use even today, nearly           
200 years after Dupuytren’s time. 
In 1906, George Thomas a Dermatologist in the College of 
Physician and Surgeon in New York, published the 1st handbook of 
treatment of burns.38 In 1917, during World War II, Sulfa drugs  and 
Penicillin were discovered which changed the approach to the treatment 
of burns totally.39  Lieutenant Colonel AJ Hull developed and patented 
No.7 paraffin associated with aseptic technique like hand washing which 
he proved reduced exposure to infections.39  In the 20th century, 
DR. DUPUYTREN 
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LouisPasteur developed aseptic techniques which decreased mortality 
and morbidity in burn patients.30 In 1875, Joseph Lister  used  boric acid 
and carbolic acid  for burn wounds to kill bacteria.28Dr. Harold Gillies a 
surgeon in Aldershot Burn unit, UK laid autologous skin graft and did 
reconstructive surgeries in burn patients.35 Robert Aldrich, used tripledye 
method.35 Gentian violet seals the wound and kills the Gram positive 
bacteria such as Staphylococcus aureus, one of the most common 
infectious agent to complicate burns.35  In 1943, The US Army Institute 
for Surgical Research (USAISR),40  situated in Fort Sam Houston, Texas 
was formed in which 300 physicians, surgeons and allied health 
professionls were committed to burn care.40Dr. Summer Koch and 
Harvey Allen of Chicago used petroleum jelly dressings for burns. This 
method gained attention to all the burn fraternity units and came to be 
known as ″Allen Koch″ method of burn treatment.35  In 1930 Frank 
Underhill , after analyzing a group of people burned in a theatre accident, 
documented articles saying that burn shock and death was due to fluid 
loss and not due to toxins which was a popular theory of that time.28  In 
1965, Moyer and associates recommended Ringer lactate solution28  for 
the burned patients .In 1978, Charles  Baxter modified this 
recommendations with the Parkland formula. With these advantages in 
the understanding of burn shock and vigorous fluid resuscitation, a 
dramatic improvement in early survival occurred.28 In 1960s, The US 
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No.7 paraffin associated with aseptic technique like hand washing which 
he proved reduced exposure to infections.39  In the 20th century, 
DR. DUPUYTREN 
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LouisPasteur developed aseptic techniques which decreased mortality 
and morbidity in burn patients.30 In 1875, Joseph Lister  used  boric acid 
and carbolic acid  for burn wounds to kill bacteria.28Dr. Harold Gillies a 
surgeon in Aldershot Burn unit, UK laid autologous skin graft and did 
reconstructive surgeries in burn patients.35 Robert Aldrich, used tripledye 
method.35 Gentian violet seals the wound and kills the Gram positive 
bacteria such as Staphylococcus aureus, one of the most common 
infectious agent to complicate burns.35  In 1943, The US Army Institute 
for Surgical Research (USAISR),40  situated in Fort Sam Houston, Texas 
was formed in which 300 physicians, surgeons and allied health 
professionls were committed to burn care.40Dr. Summer Koch and 
Harvey Allen of Chicago used petroleum jelly dressings for burns. This 
method gained attention to all the burn fraternity units and came to be 
known as ″Allen Koch″ method of burn treatment.35  In 1930 Frank 
Underhill , after analyzing a group of people burned in a theatre accident, 
documented articles saying that burn shock and death was due to fluid 
loss and not due to toxins which was a popular theory of that time.28  In 
1965, Moyer and associates recommended Ringer lactate solution28  for 
the burned patients .In 1978, Charles  Baxter modified this 
recommendations with the Parkland formula. With these advantages in 
the understanding of burn shock and vigorous fluid resuscitation, a 
dramatic improvement in early survival occurred.28 In 1960s, The US 
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Army Institute of Surgical Research team used The Magic Bullet”, the 
Penicillins  which reduced infections and its complications and as a 
consequence death due to burns started to decline steadily.35  In 1962, 
Dr.A Pruitt, dramatically improved the burn surgeries and set research 
unit on burns and is maintaining it till date.41  In 1963, the International 
Society for Burns Injuries was founded. In 1968, the American Burn 
Association was founded.28 
Since 1970 , efficient management of burn wounds  have been 
developed like Collagen sheets for I degree burns, Fresh dried Human 
amniotic membranes, Nano sheets and advanced surgery techniques 
like Escharectomy followed by Split Skin grafting. Monitoring of burn 
wound infections has also founded a drastic evolution. Over three 
decades ago, in 1974 Loebl and colleagues developed and evaluated a 
method for quantitative bacterial cultures of burn wound samples that 
have been widely adopted into practice even today by various 
modifications. 
The interest of all these people had instilled  awareness into all the 
medical fraternity directed against burn wound care. Bearing these 
valuable contributions in mind, it is imperative to develop a working 
knowledge of all the fundamental aspects of burn treatment. So as we see 
treatment of burn victims has evolved during the past 50 years into a 
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well-developed and organized super- speciality. This global perspective  
about the outcome and quality of life for survivors of  an often 
devastating injury affords us a special position in this field. 
IMMUNOLOGY IN BURN INJURY 
 Severe burn injuries cause a state of immunosuppression that 
affects innate and adaptive immune responses. The substantial impact of 
immunocompromise on infection is due to effects on both the cellular and 
the humoral arms of the immune system.42 Decrease in the number and 
activity of circulating helper T cells, increases in the number and activity 
of suppressor T cells, decrease in production and release of monocytes 
and macrophages, and diminution in levels of immunoglobulin follow 
major burns.42 Neutrophil and complement functions also have been 
shown to be impaired after burns. The increased levels of multiple 
cytokines detected in burn patients are compatible with the widely held 
belief that the inflammatory response becomes dysregulated in these 
individuals; bacterial cell products play a potent role in inducing 
proinflammatory mediators that contribute to this uncontrolled systemic 
inflammatory response. Increased permeability of the gut wall to bacteria 
and their components (eg.,endotoxins) also contributes to immune 
dysregulation and sepsis.42 Thus, a burn patient is predisposed to 
infection at remote sites as well as at the sites of burn injury. Another 
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contributor to secondary immunosuppression after burn injuries is the 
endocrine system;  increasing levels of vasopressin, aldosterone, cortisol, 
glucagon, growth hormone, catecholamines, and other hormones that 
directly affect lymphocyte proliferation, secretion of proinflammatory 
cytokines, natural killer cell activity, and suppressor T cells are seen.42 
PATHOPHYSIOLOGY OF WOUND INFECTION 
 The thickness of the epidermis and dermis vary with the site of the 
body, sex, age of patient, etc. Infants, young children, and elderly adults 
have a thinner dermal layer of their skin, resulting in deeper burn injury. 
The dermis has the ability to produce new epithelial cells to replace the 
cells that have been lost by the epidermis by means of shafts of 
appendages that are lined with epithelial cells. Both the skin layer and the 
connective tissue have nerve endings which provides a structural base for 
the skin renovation.43   Immunologically, thermal injuries cause an 
immuno compromised state . This was evident as homografts are seen to 
survive well in these patients.44,45  There are two types of immune 
responses, the innate and the adaptive responses. The first line of  defense  
is the innate immune response immediately after the damage of skin by 
the burn wound.46 When the wound is extensive, or involving major 
organ systems or is deep, the systemic component of immunity comes 
into play. 
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This response leads to varied spectrum of presentation which results in 
serious complications like systemic inflammatory response syndrome 
(SIRS), severe sepsis, and multiple organ dysfunction syndrome (MODS) 
which result in increased morbidity and mortality.47 Immediately 
after a burn, the body tries to maintain homeostasis by a process of 
contraction, retraction, and coagulation of blood vessels. Three zones 
have been described within the wound: 
 I Zone of coagulation, which comprises the dead tissues 
that form the burn eschar that is located at the centre of the 
wound. 
NORMAL SKIN 
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 II Zone of stasis, which comprises tissues adjacent to the 
area of burn necrosis that is still viable but at risk for 
ongoing ischemic damage due to decreased perfusion. 
 III Zone of hyperemia, which comprises normal skin with 
minimal cellular injury, that has predominant vasodilatation 
and increased blood flow as a response to injury. 
 
BURN WOUND DEPTH 
 First Degree Burns: Involves damage to only the epidermis and is 
rarely clinically significant but is very painful. The involved area is 
initially erythematous due to vasodilation. It is quickly followed by 
desquamation followed by complete scarless healing within 7 days. 
 Second degree burns: By definition they are partial thickness 
burns and are divided into superficial and deep category. 
1. Superficial burns involves destruction of whole of epidermis and 
with varying portions of dermis. These injuries are very painful. 
Blistering is often present. Healing occurs very rapidly and 
completely. Scarring is very minimal. 
2.  Deep burns involves destruction of most of dermis excluding the 
epithelial appendages. Heat kills the nerve endings rendering the 
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wound relatively insensate. Blistering is usually absent. Healing is 
very slow. Intense scarring is present. 
 Third degree burns: Also called as full thickness burns and 
involves the entire thickness of burns .There is no chance of 
healing. So they are routinely treated with excision and skin 
grafting. 
The burn wound surface is a protein-rich environment consisting of 
avascular necrotic tissue (eschar) that provides a favorable niche for 
microbial colonization and proliferation. The lack of vascularity leads to 
an impaired migration of host immune cells and a restriction in delivery 
of systemically administered antimicrobial agents, while toxic substances 
released by eschar tissue further impair the local host immune responses. 
Although burn wound surfaces are sterile immediately following thermal 
injury, these wounds eventually become colonized with 
microorganisms.48,49,50,51,52 Loss of cutaneous barrier facilitates entry of 
the patient’s own flora and of the organisms from the hospital 
environment into a burn wound. Initially, the wound is colonized with 
Gram-positive bacteria from the surrounding tissue, but the number of 
bacteria grows rapidly beneath the burn eschar, reaching ہ8.4x10P5 P CFU/g 
on day 4 after the burn.P42P By day 7, the wound is colonized with other 
microbes, including gram-positive bacteria, gram-negative bacteria, and 
17 
 
 
 
yeasts derived from the gastrointestinal and upper respiratory flora. 
Invasive infections either localized or systemic, occurs when these 
bacteria penetrate viable tissue.42 In the light of any difficulty in 
evaluating burn wounds solely on the basis of clinical observation and 
laboratory data, wound biopsies are necessary for the definitive diagnosis 
of infection. The timing of these biopsies can be guided by clinical 
changes, but in some centres burn wounds are biopsied routinely at 
regular intervals. The biopsy specimens is examined for histologic 
evidence of bacterial invasion, and quantitative microbiologic cultures are 
performed. The presence of >105 viable bacteria per gram of tissue is 
highly suggestive of invasive infection and of a dramatically increased 
risk of sepsis. 
MICROBIAL ETIOLOGY 
 Microorganisms colonizing the burn wound originate 
endogenously from the patient’s skin, gastrointestinal and upper 
respiratory tracts. There are abundant microflora normally present in the 
gut, oral cavity and vagina. Microorganisms maybe transferred to a 
patients skin surface by contact with contaminated external environment, 
water, fomites, air and also contaminated hands of the health care 
workers.53 Colonization occurs in slow healing wounds which are 
continuously exposed to devitalized tissue. 
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 Initial invaders are the Gram-positive bacteria coming either from 
the patient’s endogenous skin flora or from the external environment.54 
Wounds with hypoxic environment are susceptible to colonization by 
various endogenous anaerobic bacteria. When wounds are investigated by 
appropriate microbiological techniques, anaerobes are found in large 
numbers. Wound colonization by yeasts and fungi occurs later due to the 
use of broad-spectrum antibiotic therapy.55 Microorganisms acquired 
from the hospital environment tend to be more resistant to antimicrobial 
agents than those originating from the patient’s normal flora.56 Table 2 
lists the microorganisms of the burn wound infections.24,37 
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Table 2-Microorganisms causing invasive burn wound infections 
Gram positive Staphylococcus aureus 
Methicillin Resistant Staphylococcus aureus 
Coagulase negative staphylococcus 
Enterococcus species 
Vancomycin resistant enterococcus 
Beta hemolytic Streptococcus Group C 
Beta-hemolytic Streptococcus Group A 
Gram negative 
bacilli 
Pseudomonas aeruginosa  
Escherchia coli 
Klebsiella pneumonia 
Serratia marcescens 
Proteus species 
Acinetobacter species 
Enterobacter species 
Citrobacter species 
Stenotrophomonas maltophila 
Providencia species 
Morganella species 
Anaerobic organism Clostridium species 
Peptostreptococcus species 
Bacteroides species 
Prevotella species 
Porphyromonas species 
Propionibacterium species 
Eubacterium species 
Fusobacterium species 
Veillonella species 
Fungi Candida species 
Aspergillus species 
Fusarium species 
 Alternaria species 
Rhizopus species 
Mucor species 
Viruses Herpes simplex virus 
Cytomegalovirus 
Varicella zoster virus 
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Prior to the antibiotic era, Streptococcus pyogenes (Group A beta-
hemolytic Streptococci) was the predominant pathogen implicated in burn 
wound infections and a major cause of death. With the introduction of 
Penicillin, in 1950’s, Streptococci was wiped off and replaced by 
Staphylococcus aureus. Till today, Staphylococcus aureus remains a 
common cause of early burn wound infection. Slowly then, evolved 
among the Gram-negative organism was Pseudomonas aeruginosa which 
originated from the patient’s gut flora or an environmental source and 
became one of the foremost causes of burn wound infections in many 
centres.59 There was a steady increase in the incidence of rare pathogens 
also.60    Less commonly, infections due to anaerobic bacteria typically 
occur secondary to electrical burns or open wound dressings were used 
instead of occlusive dressings.61 
Development of antimicrobial resistance throughout the world 
against a variety of bacterial and fungal pathogens, particularly 
nosocomial isolates limits the therapeutic options available for an 
effective treatment.59 Methicillin resistant Staphylococcus aureus, 
Vancomycin resistant Enterococcus and multi drug  resistant Gram-
negative bacteria that possess several types of beta-lactamases, Amp C 
beta lactamases and metallobeta-lactamases have been emerging as 
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serious pathogens in hospitalized patients.58 Fungal pathogens, 
particularly Candida species, have increasingly become important 
opportunistic pathogens due to the use of broad-spectrum topical and 
systemic agents when infection occurs in the burned patient and have 
demonstrated increasing degrees of antifungal drug resistance.62 
EPIDEMIOLOGY OF BURN INFECTIONS 
The development of infection in a burn patient depends on the presence 
of three conditions, often called the chain of events: 
(1) A source of organisms capable of producing disease 
(2) A mode of transmission, and 
(3) A susceptible host 
 
SOURCES OF ORGANISMS 
Sources of organisms can be found within the patient’s own endogenous 
flora, including organisms commonly harboured on the skin in the 
gastrointestinal tract, and in the upper respiratory tract. The types, 
amounts, and relative antimicrobial resistance of these organisms vary 
depending upon the patient’s age, percentage of the total body surface 
area (TBSA) burned62   and the antibiotic and other therapies needed to 
treat the burn injury. 85% - 95% of infections in burn patients originated 
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from the patient’s endogenous flora63   . Exogenous organisms emanate 
from the surrounding inanimate environment and from personnel. These 
organisms  are generally more resistant to antimicrobial agents than 
endogenous organisms63,64 . 
MODES OF TRANSMISSION 
Modes of transmission include contact, droplet, and airborne spread. 
Among burn patients the primary mode of transmission is direct or 
indirect contact, principally via (1) the hands of personnel caring for the 
patients and (2) contact with inappropriately decontaminated equipment. 
Burn patients are unique in their susceptibility to colonization and 
infection from organisms in the environment and in their propensity for 
dispersing organisms into the surrounding environment, the degree of 
which is directly related to the percentage of burn injury. Adequate 
understanding  and appreciation of this fact are essential to establishing 
effective infection control strategies for these patients. 
HOST SUSCEPTIBILITY 
The body has three principal defenses against infection: physical 
defences, nonspecific immune responses , and specific immune 
responses. Alterations of these defences determine the individual’s 
susceptibility to infection. Physical defences  are greatly altered by 
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consequences of burn injury. Intact skin provides a physical barrier, 
normal flora, low pH maintained by fatty acids and dryness, desiccation 
and desquamation which is altered altogether by the burn injury. This is 
evidenced by the loss of epidermis and all or part of dermis, depending on 
depth of injury. This allows penetration of organisms into viable tissue of 
wound and into body, including the bloodstream. Also fosters shift in 
colonizing flora from skin organisms (coagulase-positive and negative 
streptococci, diphtheroids) to enteric gram negative organisms, 
pseudomonas and fungi. Invasive devices contribute to colonization by 
hematogenous seeding of organisms from the burn wound65  . Extremes of 
age associated with changes in the body’s defence mechanisms both in 
immune system functioning and in physical mechanisms. In elderly 
patients, preexisting medical conditions and waning immune function are 
of particular consequence because both can increase these patient’s 
susceptibility to infection62. In children, susceptibility to common 
communicable childhood diseases poses a challenge for infection control 
and this may cause serious consequences if superimposed  in a patient 
with a burn injury66  .  
GLOBAL BURNS LOAD 
Burn injuries are among the most devastating of all injuries and a major 
global health crisis.67,68Burns are the fourth most common type of trauma 
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worldwide, following traffic accidents, falls, and interpersonal 
violence.69,70   Approximately 90 percent of burns occur in low to middle 
income countries, regions that generally lack the necessary infrastructure 
to reduce the incidence and severity of burns. According to Rethink 
Burns, ReSurge International ,International Medical Corps,2013 , half of 
the world’s population, three billion people, still use open flames to cook 
for their families and to heat and light their homes. Ninety-five percent of 
all burns injuries happen in developing countries where prevention is 
almost non-existent and medical care for burns is extremely limited. This 
caused millions of needless deaths or disabilities, even for relatively 
minor burns. Without immediate access to adequate burn care, burn 
injuries are left to heal by themselves, creating scar tissue (contractures) 
that can destroy function and movement, and cause disfigurement in ways 
unimaginable. In the developing world, countless men, women and 
children suffer unnecessarily from injuries and disabilities that could be 
prevented and treated.73 
 Nearly 11 million people worldwide are burned severely enough to 
require medical attention annually, according to WHO estimate of 2004. 
More women worldwide are severely burned each year according to new 
2010 Global Burden of Disease Study, burn remain a leading cause of 
morbidity and mortality. 
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 According to the Global Burden of Disease Study,2010, more than 
330,000 people die of burn injuries every year, 307,000 in developing 
countries; 43% are under 30 years; 20% are children; more than half live 
in South Asia (India, Bangladesh, Nepal, Pakistan, Bhutan and 
Afghanistan); and a more than a fourth live in Sub- Saharan Africa. 
 Burns also cause more than 19 million DALYs (Disability adjusted 
life years); productive year lost to being disabled from a disease or injury. 
It is also in the top 25 causes of morbidity in South Asia and Sub Saharan 
Africa; the 28th in all developing countries, 27th for women and girls. 
 South Asia is at the epicenter of the burn crisis, and nearly a third 
of all deaths from burns globally happen to women and girls in that 
region. There, more women and children die from severe burns than from 
any other disease. It is also the 6th leading cause of lost productive years 
(DALYs) for women aged 15-49. 
 In Sub Saharan Africa, burns are also the 19th leading cause of 
death, the 16th for the ages 15-49. Infants in Africa have 3 times the 
incidence of burn deaths than infants worldwide. 
 WHO mortality data that includes the International Classification 
of Disease Codes which allows disaggregation into subtypes of burns. 
These data show fire-related burns made up of 93% of all deaths, scalds 
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contributed 5.4% and the rest; 1.6% were as a result of contact, chemical 
or electrical burns74  . 
BURNS LOAD IN INDIA 
Burns is a special type of trauma which is dependent on many 
factors like the habits of the community, the culture of the society, the 
socioeconomic status of the people, the religious beliefs, environmental 
conditions and the psychological behavior of the population.75 All these 
factors feature in causation of burns in India. Fire is an integral part of 
Indian lifestyle. Fire is used in different forms during daily chores. Be it 
morning worship, cooking, lighting and festivities, everything revolves 
around fire. Hence it is likely that the Indian community is more prone to 
the occurrence of burns. Understandably, the burn is more prevalent in 
people of lower socioeconomic status.75 Electricity is unsafe in many of 
our houses and establishments, cooking gas is prone to accidents, 
chemicals that can cause accidental burns are easily available, fire 
crackers being a part of all our festivities and many more issues favor the 
occurrence of burns in India. On the other hand, in the developed 
countries, individuals do not come in contact with fire very often. The 
closest they come to fire is while lighting candles for worshiping in the 
church. The presence of smoke detectors prevents use of fire at home, as 
well as at the workplace.75 
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Approximately 7 million people sustain burns in India every year, 
out of which 700,000 patients (10%) require admission76 . Half of the 
hospital burn patients  sucuumb to the injury. Majority of the burns  in 
India do not report to hospitals. 70% of Indian population live in the 
villages and rural areas. They do not have access to hospitals. Almost all 
minor burns do not report to hospitals. Many major burns are treated in 
place other than recognized  burn hospitals and quite a few by a 
unqualified persons and hence remain unreported75 . Only a section of the 
patients with major and moderate burns report to hospitals for treatment 
and are reflected in the hospital statistics. The patients who report to the 
hospitals form only the tip of the iceberg. 
 In contrast to the developed world, the burn load in developing 
countries is many folds higher. As per the report of the Indian National 
Crime Records Bureau (INCRB) of 2007, out of 340,794 total accidental 
deaths, 20,772 (6.2%) were due to fire accidents. There were 10,391 
(8.5%) deaths classified as suicidal burn deaths out of a total of 122,637 
suicidal deaths. The mortality due to burn injuries was reported as 3.5 per 
100,000  population.77 
 India, the second most populous country in the world over a billion 
people has an estimated annual burn incidence of 6-7 million, based on 
data from three major hospitals when extrapolated to whole of the 
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country. This is the second largest group of injuries after road accidents. 
But there is a silver lining that 90% of all burn injuries are preventable. 
This burn scenario is grave not only due to the high incidence but is also 
compounded by absence of any organized burn care at primary and 
secondary health  care level. Patients have to travel a long distance to 
metropolitan cities for management of their burn injuries. The recent rise 
in the incidents of terrorist activities and other man-made disasters, are 
contributing to a quantum jump in Burn injury cases also highlights 
reason for national preparedness to cope with the challenge of this Public 
Health Programme. 
 So the Ministry of Health and Family Welfare, government of 
India have under consideration a proposal to introduce a National 
Programme for Prevention of Burn Injuries (NPPBI) in all the 
states/Union Territories of the country during the 12th five Year Plan 
(2012-17). 
The goal of National Programme for Prevention of Burn Injuries would 
be, as the name itself suggests, to ensure prevention of Burn Injuries, 
provide timely and adequate treatment in case burn injuries do occur, so 
as to reduce mortality, complications and ensuring disabilities, and to 
provide effective rehabilitative interventions if disability has set in. 
Having identified that burn injury is a potential Public Health Hazard, in 
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order to reduce incidence and its consequential trauma in the country, a 
coordinated programme for Burn Injuries was conceived as a new 
initiative during the year 2010 and a Pilot Programme for Prevention of 
Burn Injuries (PPPBI) was launched in 3 states namely Assam, Haryana 
and Himachal Pradesh in a limited scale. Under this programme the 
government of India provided financial support to the extent of Rs.2.00 
crores for the Construction of 12 bedded (8 beds + 4 ICU beds) Burn Unit 
and Rs.98 lakhs for the purchase of essential equipments for the Burn 
Unit.78 
MICROBIOLOGICAL ANALYSIS OF BURN WOUND 
INFECTIONS 
 Diagnosis of burn wound infection based on clinical signs and 
symptoms alone is difficult. Monitoring of the burn wound by regular 
sampling is essential. This is done  either by a surface swabbing  or tissue 
biopsy . Tissue biopsy and quantitative bacterial count of verification of 
microbial invasion into viable unburned tissue have been the ‟gold 
standard ” to confirm invasive burn wound infection57. As it is a quite 
laborious and costly procedure, many burn centres have shifted to procure 
burn wound surface swabs for qualitative or semiquantitative culture for 
monitoring the burn wound infection.79,80,81Deirde Church et al discuss 
the various diagnostic microbiological approaches to diagnose a burn 
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wound infection. They also suggest the current recommendations for 
surveillance of  burn wound infection. 
 Review of the literature of various burn wound studies comparing 
surveillance of burn wound by surface swabs and burn wound biopsy 
always provides conflicting results about the best approach. The different 
studies provides conflicting results due to the following reasons: 
 Burned patients do not have same type of injury so  that the 
severity and extent of the burn injury vary greatly from patient to patient. 
Many studies were done using various sampling techniques and 
microbiological methods , and comparative studies were done before the 
advent of early excision therapy.84,85,86 Steer and colleagues, have 
reported the recent largest studies and compared the results of biopsy 
cultures and surface swabs.87,88 In their initial study qualitative and 
quantitative bacterial counts were compared. Although there was a 
significant correlation between the bacterial counts obtained by biopsy 
and swab, the counts obtained by one method were poorly predictive of 
the counts obtained by the other. Also, parallel cultures taken on multiple 
occasions showed a significant correlation between bacterial counts 
obtained from two biopsies or two swabs simultaneously, but there was 
wide variation in bacterial densities from the same burn wound at the 
same time. The study concluded that the use of quantitative assay in 
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burns is limited by the unreliability of a single surface swab or biopsy 
sample to represent the whole burn wound. 
 Steer and coworkers in their work studied a relationship between 
bacterial counts collected by surface swabs and burn wound biopsy 
cultures.87They collected both the specimens either immediately prior to 
excision and grafting or during routine dressing changes. From their 
study they demonstrated that quantitative bacteriology by burn wound 
biopsy or surface swab does not aid in the prediction of sepsis or graft 
loss. 
 Loebl and colleagues demonstrated that the microorganisms 
obtained from the burn wound surface which was not excised showed 
poor correlation with that of tissue biopsy samples taken from the sub-
eschar tissue. Freshwater and Su observed that the quantitative burn 
wound cultures  should be clinically correlated with the burn wound 
infection and reported accordingly so that it serves as a useful guide in 
the management of burns patients with large TBSA burns.79 Tahlan and 
colleagues also compared surface swabs and the burn wound biopsy 
cultures in their study in second and third degree burns.83 They did not 
observe any difference in the isolates from the swabs and wound biopsies. 
Levine and colleagues   compared swab and tissue biopsy specimens 
observed a numerical relationship between these two, whereby counts of 
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105 bacteria per gram of tissue in the biopsy sample and compared with 
counts of 106 bacteria obtained from surface swabs.16 
 McManus and colleagues found  out that quantitative assay of 
tissue biopsy specimens was superior method to assess the 
microorganisms in the burn wound.80 Sjoberg and colleagues in their 
study demonstrated that quantitative assay of tissue biopsies was a better 
method to assess sepsis to surface swabs but also noted that the procedure 
was very laborious regarding collection and analysis of the multiple 
samples.86 Herruzo-Cabrera and colleagues observed that a method using 
semi-quantitative surface swab to distinguish between wound 
contamination and infection, using 105 organisms per gram as a threshold 
for the definition of infection by biopsy.89 Bharadwaj and colleagues 
showed that blood cultures were also valuble in assessing burn wound 
sepsis when compared to that of swab or tissue biopsy cultures.26 Their 
study showed that eventhough blood cultures were positive it proved to 
be a late sign in assessing invasive burn wound invasion. 
 For routine surveillance of the burn wound infections the apt 
sampling technique should be adopted according to the area of the burn 
wound as no single method provides a clinically reliable data on both the 
eschar and the areas excised. Superficial swab proves to be a most 
convenient  and least invasive approach to provide the microbial flora 
33 
 
 
 
present in the wound surface. Moreover swabs can be taken from areas 
where skin is very thin to be biopsied like ears, eyes and phalanges. But a 
coordinated approach using quantitative tissue biopsy, blood, and urine 
samples can provide a best approach in assessing the burn patients with 
sepsis.57 Deidre Church and colleagues  also state that tissue biopsy 
samples should be sent for quantitative culture from burn wound in 
patients with sepsis.57 They also state that tissue biopsy is necessary in 
order to diagnose unusual types of burn wound infections due to fungi 
and viruses. 
BURN WOUND SAMPLING TECHNIQUES 
 There are various methods present for the surveillance of burn 
wound infections. The sample should be taken on regular basis, by a 
surface swab or by tissue biopsy.,90,91,92,93 Multiple samples from several 
areas of the burn wound should be collected so that accurate 
determination of the amounts and the type of microorganisms isolated can 
be assessed irrespective of sampling technique. For the first few days to 
weeks after the injury samples should be collected frequently when the 
microbial flora is evolving. Then on, can be decreased to weekly, once 
the eschar has been excised, provided clinical signs of infection are not 
present. 
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SUPERFICIAL WOUND SAMPLES 
 Superficial wound samples consisting of qualitative and 
semiquantitative methods which are routinely employed in all clinical 
microbiological laboratories. Various techniques are employed including 
contact plates, collection of swabs and capillary guaze sampling.16,86,93,94 
Modern burn units universally rely on collection of swabs though other 
methods are described for only historical completeness. Surface swabbing 
must be done after the removal of dressings and surgical antibacterial 
agents and cleansing of the wound surface with 70% alcohol.16,26,87,88 
Surface swabs of the burn wound are a convenient and effective method 
for the routine collection of multiple samples.16,88 The best method of 
surface swabbing is moving the sterile swab over an area of 1cm of the 
wound applying adequate pressure on the underlying tissues as to cause 
sufficient bleeding. Methods involving both dry and moist swabs have 
shown that moist swab technique provides better reproducibility.84 
Capillarity gauze sample collections are done by applying moistened 
guaze squares to the  open wound surface for several minutes followed by 
inoculation into the agar plate.93,94 This quantitative culture is more 
reproducible as the capillarity guaze provides more harvest of the resident 
bacteria.93 
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TISSUE BIOPSY 
 In an unexcised wound multiple samples from the subeschar tissue 
and quantitative culture has been historically the primary method for the 
accurate assessment of the unexcised burn wound.82,85,95After the study of 
Loebl and colleagues the quantitative biopsy culture was widely adopted 
into practice.82,85  Initially the burn wound is cleaned with isopropyl 
alcohol, then two parallel incisions are made in the skin approximately 1 
to 2 cm in length and 1.5 cm apart. With a help of a sterile forceps the 
tissue is elevated and with a scalpel the subcutaneous tissue is cut to a 
sufficient depth to obtain a small portion of the healthy underlying fat. 
Biopsy samples can also be collected by 3-mm punch biopsy. 
Histopathological evaluation can detect bacteria, fungus by 
Periodic acid –Schiff (PAS) and Gomori methenamine silver (GMS), but 
cultures must be obtained to definitely identify and give sensitivity of the 
pathogen. Viruses like Herpes simplex virus (Giemsa) can be retrieved 
from the wound and identified by the presence of inclusion bodies in the 
microscope. Histology also guides in the staging of the burn wounds.96,97  
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The various stages used to diagnose burn wound infections are as 
follows: 
STAGE I – COLONIZATION 
a. Superficial – Microorganisms present only on burn wound 
surface 
b. Penetrating – Variable depth of microbial penetration of eschar 
c. Proliferating – Variable level of microbial proliferation at 
nonviable-viable tissue interface (subeschar space) 
STAGE II – INVASION 
a. Micro-invasion – Microorganisms present in viable tissue 
immediately subjacent to subeschar space 
STAGE III -  DEEP INVASION 
a. Penetration of microorganisms to variable depth and expanse 
within viable subcutaneous tissues. 
b. Micro-vascular involvement: Microorganisms within small 
blood vessels and lymphatics (thrombosis of vessels is 
common) 
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SAMPLING TECHNIQUES FOR OTHER PATHOGENS 
 Various methods are employed for the recovery of anaerobic 
bacteria, fungi and viruses from the burn wound. Anaerobic swab systems 
and pre-reduced anaerobic  media  that  provide a suitable environment 
for the transport of inoculated surface swabs are commercially 
available.98 To maintain the viability of anaerobic bacteria, the Copan VI-
Pak agar gel collection system for a 24 hour transport.99 However, tissue 
biopsy samples placed in saline moistened guaze maybe more reliable for 
the recovery of all anaerobic species from the burn wounds. For viruses 
and fungi, tissue biopsy for culture, immunofluorescence testing for 
viruses such as herpes simplex virus, and histology appear to be the most 
diagnostic methods. 
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                 MATERIALS AND METHODS 
 
 
MATERIALS AND METHODS 
Place of study                       Thanjavur Medical College, Thanjavur 
Study period                            One year (June 2013 to 2014) 
Collaborating Departments  Departments of Surgery and Plastic Surgery 
Design of study                    Prospective and Observational Study 
Ethical Committee Clearance  Prior approval obtained from Ethical Committee 
Informed Consent Obtained from each patient 
Sample Tissue biopsy specimen 
 
                                 -----------   ∗∗∗∗∗  ----------- 
During the study period from June 2013 to July 2014, a total 
number of 246 tissue biopsy samples were collected from 83 patients 
with burns wound admitted at Thanjavur Medical college Hospital, 
Thanjavur. The samples were processed in the Central Service 
Laboratory, Microbiology Department, Thanjavur Medical College 
Hospital. For collection of the sample the following inclusion and 
exclusion criteria were considered. 
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INCLUSION CRITERIA 
 All age groups and gender 
 Patients with burn wounds ranging from 10% to 70% Total 
Body Surface Area Burns 
 Patients with burn wound who are about to be grafted 
 
EXCLUSION CRITERIA 
 Patients with burns associated with chronic diseases like 
diabetes, etc 
 Patients with burn wound less than 10% and more than 70% 
 Patients with burn wound with clinical signs of septicaemia. 
 
SPECIMEN COLLECTION 
 According to the above criteria the samples were collected. 
Samples from the burn wounds were collected by both surface swabbing 
and  by tissue biopsy technique. 
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SURFACE SWABBING 
To obtain a culture of burn surface, topical agents were first removed 
with a guaze soaked in sterile saline. The method of collection was deep 
swabbing, or aspiration of the bleb. Then the sample was collected by two 
sterile swab sticks. For dry wounds the swab was moistened with sterile 
saline. After the collection, the swab were immediately transported to the 
laboratory for further processing. 
TISSUE BIOPSY SAMPLE 
 For quantitative cultures of biopsy samples, the wound was washed 
with saline soaked guaze pads to wash off the topical agents. The wound 
was biopsied by making two parallel incision by means of 11 blade, 
approximately 1 to 2 cm in length and 0.5 cm apart. Then the tissue was 
elevated by Alleys’ Forceps and cut to a sufficient depth to obtain a small 
portion of the healthy underlying fat 82. The tissue was placed directly  
into  a  sterilized pre-weighed homogenizer bag containing 1ml normal 
saline and the bag re-weighed. Weight of the tissue was obtained by 
subtracting the first weight from the second by the formula 
    C = B – A 
Where,  C = weight of the tissue 
     B = weight of bag with saline and  
    A = weight of bag with saline. 
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This method of quantitative cultures were initially developed by 
Loebl85.He collected the tissue sample by making two parallel incisions 
and by means of sterile tissue forceps elevated and biopsied the sample 
by means of a scalpel. Then he macerated the tissue and made several 
dilutions. Lawrence described as open method.14 Baxter 10 homogenizes 
the tissue with the help of knife after suspending it in 1-2 ml of normal 
saline.Homogenization can also be done with a mortar and pastle.Robson 
et al15  used a polytron homogenizer.Ganatra et al100 used a punch biopsy 
forceps followed by homogenization in a Lab Blender Stomacher. 
Buchnan et al101 used a sterile scalpel blade and forceps and cut into small 
pieces  and homogenization carried out in a Ten Broeck tissue grinder. 
SPECIMEN PROCESSING 
The samples from both the surface swabbing and tissue biopsy collected 
from the burn patients were immediately transported to the laboratory for 
further processing. 
SURFACE SWABBING 
One of the swab sticks was used for direct gram staining. By the 
other  swab stick, the sample was inoculated in MacConkey and blood 
agar plates and incubated for 18 to 24 hours at 37 ̊ C. At the end of the 
incubation period, the plates were examined for the isolates. 
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TISSUE BIOPSY SAMPLE 
The tissue placed in a homogenizer bag with 1ml of normal saline 
was homogenized in a tissue homogenizer (Lab Blender stomacher 80) 
for 30 seconds. Then with the homogenate, gram staining and quantitative 
bacteriology was performed simultaneously. 
QUANTITATIVE BACTERIAL ASSAY 
Then with the homogenate, several dilutions were made in the 
Laminar Flow Hood. Four test tubes containing 4.5 ml of normal saline 
each was taken. 0.5 ml of the homogenate is taken from the homogenizer 
bag with the help of a Micro pipette and added to the first test tube 
containing 4.5 ml of normal saline mixed well and the microtip was 
discarded. With a new microtip  0.5 ml was transferred to the second 
tube, mixed well and the micro tip was discarded. With a new microtip 
0.5 ml is transferred to the third tube, mixed well and added to the fourth 
tube and then 0.5 ml taken from the fourth tube is discarded. Thus four 
dilutions  were made, that is, 1/10, 1/100, 1/1000, 1/10000. Over three 
decades age, Loebl82 and colleagues developed and evaluated a method 
for quantitative bacterial cultures of burn wound samples and have been 
widely adopted into practice. In this study a method  is adapted similar to 
that described by Loebl with one difference is that Lab Bender Stomacher 
80  has been used which ensures sterile and safe method. 
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First direct Gram staining was done from the homogenate fluid. 
Pus cells, Gram positive and Gram negative organisms were noted. 
MacConkey agar plates and Blood agar plates were kept ready for 
inoculation. Each plate was divided into four quadrants and labelled as 
1/10, 1/100, 1/1000, 1/10000. 0.01ml of homogenate is taken from each 
dilution tube and dropped in the MacConkey and Blood agar plates from 
a height of 2.5cm100   .Plates are then placed in the incubator with the lids 
slightly open for 15 minutes and then closed and incubated for 24 hours 
at  37°C. After the incubation period, the surface forming colonies were  
noted  for its morphological characteristics like opaque, moist or mucoid 
colonies, whether lactose fermenter or non-lactose fermenter, whether 
hemolytic or non-hemolytic and whether the isolate was single or 
multiple. Special characteristics were also looked for like swarming and 
for any specific odour. The number of colonies were counted by a hand 
lens and colony count per gram of tissue was calculated. 
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PROCESSING OF THE TISSUE BIOPSY SPECIMEN 
 
 
 
 
 
 
The colony count per gram of tissue was obtained by the formula 
of Miles and Misra102 
 
CFU/gm of tissue = C x D x V/W x 0.01 
 
Where     C = the total number of Colony forming units 
D  = is the dilution factor 
                W = the weight of the tissue 
V =  the volume of normal saline 
0.01 = the volume of the inoculum 
 
Bacterial isolates were identified by adopting the procedures of Gram 
staining, motility and routine biochemical reactions. The Gram’s staining 
was done from the colonies for both the swab specimen and the tissue 
homogenate fluid. The Gram positive and Gram negative organisms were 
noted and biochemical reactions performed accordingly. For the Gram 
positive organisms, Catalase test and coagulase test and other 
biochemical reactions was done. For Gram negative organisms Catalase 
test, oxidase test, motility test was done followed by Indole test, Methyl 
Red Test, Voges Proskauer Test, Citrate test, Urease test, nitrate 
reduction test, TSI test ,LAO decarboxylation, and OF test were done and 
results were recorded. On the basis of these tests, the organisms were 
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 COLONIES OF KLEBSIELLA PNEUMONIAE 
COLONIES OF PSEUDOMONAS AERUGINOSA 
 
 
identified and noted. Then speciation was also done for each isolate. 
Quality control was also performed for all the standard tests. 
 
IDENTIFICATION AND SPECIATION OF THE ORGANISM 
1.Staphylococcus aureus 
 Grampositive cocci in clusters 
 Motility – non-motile 
 Catalase – positive 
 Slide Coagulase – positive 
 Tube coagulase - positive 
 Β-Haemolysis  - positive 
 Indole  production - negative 
 Methyl red test – positive 
 Voges Proskauer test – positive 
 Citrate Utilization test – negative 
 Urea hydrolysis test – positive 
 TSI – A/A  
 nitrate reduction test – positive 
 OF test - fermentative  
 Modified Oxidase test – negative 
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2. Klebsiella pneumonia:  
 Gram negative rods 
 Catalase test – positive 
 Oxidase test – negative 
 Motility test –  non-motile  
 Indole production - negative 
 Methyl red test –negative 
 Voges Proskauer test –positive 
 Citrate Utilization test – positive 
 Urea hydrolysis test – positive 
 nitrate reduction test – positive 
 Triple sugar iron agar test – A/A with gas 
 LAO decarboxylation – lysine + , arginine - , Ornithine – 
 
 3. Klebsiella Oxytoca:  
 Gram negative rods 
 Catalase  test - positive 
 Oxidase test – negative 
 Motility – non-motile 
 Indole – positive 
 Methyl red test – negative 
 Voges Proskauer test –positive 
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 MAC - STAPHYLOCOCCUS AUREUS COLONIES 
MAC – KLEBSIELLA PNEUMONIAE COLONIES 
 
 
 Citrate Utilization test – positive  
 Urea hydrolysis test – positive 
 Nitrate Reduction – positive 
 Triple Sugar Iron agar test –A/A with gas 
 LAO decarboxylation – lysine + , arginine - , Ornithine – 
 
4. Escherichia coli  
 Gram negative rods, 
 Catalase test - positive 
 Oxidase test -  negative 
 Motility – motile 
 Indole – positive 
 Methyl Red test– positive 
 Voges Prauskauer test– negative 
 Citrate  utilization test–negative 
 Urease test – negative 
 Nitrate Reduction test  - positive 
 Triple Sugar Iron agar test –A/A  
 LAO decarboxylation – lysine + , arginine - , Ornithine + 
5. Proteus mirabilis: 
 Gram negative rods 
 Catalase - positive 
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 Oxidase -  negative 
 Motility –actively motile 
 swarming - positive 
 Indole -  negative 
 Methyl red test – positive 
 Voges Proskauer test – positive 
 Citrate  - negative 
 Urease -  positive 
 Nitrate Reduction test – positive 
 Triple sugar iron agar test  – K/A with abundant H2S 
 Phenyl alanine deaminase test – Positive 
 LAO decarboxylation – lysine - , arginine - , Ornithine + 
 
6. Enterobacter aerogenes  
 Gram negative rods 
 Catalase – positive  
 Oxidase – negative 
 Motility- motile 
 Indole - negative 
 Methy red test- negative  
 Voges Proskauer – positive 
 Citrate – positive 
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 Urease – negative 
 Nitrate reduction test  - positive  
 Triple Sugar Iron agar test –A/A with gas 
 LAO decarboxylation – lysine + , arginine - , Ornithine + 
 
7. Citrobacter freundii:  
 Gram negative bacilli 
 Catalase  - positive 
 Oxidase – negative 
 Motility – motile 
 Indole – negative 
 Methyl red test – positive 
 Voges Proskauer test – negative 
 Citrate – positive 
 Urease – positive 
 Nitrate Reduction – positive 
 Triple Sugar Iron agar test –A/A with H2S 
 LAO decarboxylation – lysine - , arginine + , Ornithine – 
 
8. Pseudomonas aeruginosa:  
 Gram negative bacilli 
 Catalase – positive 
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 Oxidase – positive 
 Motility – motile 
 Indole – negative 
 Methyl red test – negative 
 Voges Proskauer test – negative 
 Citrate  utilization test – positive 
 Urease test – negative 
 Nitrate Reduction test – positive 
 Triple Sugar Iron agar test –K/NC,  
 LAO decarboxylation – lysine - , arginine + , Ornithine – 
 OF test -  oxidative 
 
9. Acinetobacter baumanni:  
 Gram negative coccobacilli 
 Catalase  - positive 
 Oxidase -  negative 
 Motility – non-motile 
 Indole- negative 
 Methyl Red test - negative 
 Voges Proskauer test - negative 
 Citrate  utilization test - positive 
 Urease  test - negative 
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 Nitrate Reduction - negative 
 Triple Sugar Iron agar test  –K/NC,  
 Growth at 42̊ C  - positive  
 OF test  - oxidative 
 LAO decarboxylation – lysine - , arginine + , Ornithine – 
 1% lactose -  acid production   
 10%  lactose - acid production  
 
ANTI-MICROBIAL SUSCEPTIBILITY TESTING 
 Antimicrobial susceptibility test was done for all bacterial isolates 
as per CLSI guidelines by Kirby Disk Diffusion method on Muller 
Hinton agar. 
 
STORAGE OF DRUGS 
 The antibiotic sensitivity was done by following the clinical and 
laboratory standards institute guidelines. The antimicrobial discs were 
stored at 4-8 ̊ C but the Beta lactum drugs like clavulanic acid and 
carbapenem group of drugs are stored in freezer ie, -20 ̊ since they are 
heat-labile agents. 
 The antimicrobial discs were brought to room temperature one to 
two hours before the procedure. The disc cartridge was always secured to 
52 
 
 
 
seal tightly after taking the disc out every time. All the disc cartridges 
were placed in air tight dry container. 
 
PREPARATION OF TURBIDITY STANDARDS 
 Use of a standard inoculum size is important for culture purity and 
is accomplished by comparison of the turbidity of the organism 
suspension with a turbidity standard. McFarland turbidity standards, 
prepared by adding various volumes of  1% sulphuric acid and 1.175% 
barium chloride to obtain a barium sulphate solution with a specific 
optical density. 
 The most commonly used is the McFarland 0.5 Standard, which 
contains 99.5 ml of 1% sulphuric acid and 0.5 ml of 1.175 % barium 
chloride. The solution is dispensed into tubes comparable to those used 
for inoculum  preparation which are sealed tightly and stored in the dark 
at room temperature. 
The McFarland 0.5 Standard provides a turbidity comparable to 
that of  a bacterial suspension containing approximately 1.5 x 108  
CFU/ml. Matching turbidity using the unaided eye is facilitated by 
holding the bacterial suspension and McFarland  tubes side by side and 
viewing them against a black-lined background. 
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PREPARATION OF INOCULUM 
 The pure inoculum was obtained by selecting the 4-5 representative 
colonies of same morphology inoculated in 4-5 ml of peptone water and 
allowing the organism to achieve good active growth (ie, mid logarithmic 
phase) by incubation at 37 ̊ C for 2-6 hours. The growth was indicated by 
observable  turbidity  in  the broth. The growth turbidity compared with 
0.5 McFarland’s Standard which corresponds to 150  million 
organisms/ml.  If the bacterial suspension does not match the standard’s 
turbidity, the suspension may be diluted or supplemented with more 
organisms as needed. 
 
ANTI-BACTERIAL SUSCEPTIBILITY TEST PROCEDURE 
15-20 ml of sterilized Mueller Hinton Agar medium was poured 
into each sterile petridishes and allowed to solidify. The test bacterial 
cultures were evenly spread over the media and excessive inoculum 
drained off. The panel of antimicrobial disc for Gram positive isolates 
like Ampicillin(10μg), Erythromycin(15μg), 
Cotrimoxazole(1.25/23.75μg),  Doxycycline(10μg),  Amikacin,(10μg),  
Gentamicin(10μg), Ciprofloxacin (10μg), Ofloxacin(30μg), 
Cephelexin(30μg), Ceftriaxone (30μg), Cefoxitin (30μg), Linezolid 
(30μg) and Vancomycin (30μg) were tested appropriately for each 
isolate. The panel of antimicrobial disc for Gram negative isoaltes like 
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ESCHERICHIA COLI 
 
 
Ampicillin (10μg), Tobramycin(10μg) , Cotrimoxazole (1.25/23.75μg), 
Amikacin (10μg), Gentamicin (10μg), Ciprofloxacin (10μg), Cephelexin 
(30μg), Cefotaxime (30μg), Ceftriaxone(30μg), Ceftazidime(30μg), 
Ceftazidime+clav(30μg),Piperacillin+Tazo(100/10μg), Aztreonam(30μg), 
and  Imipenam(10μg) were tested. The discs were  placed on agar plates 
and pressed down to ensure complete contact with the agar surface. Discs  
were distributed evenly so that they were not closer than 25 mm from 
centre to centre of the disc and incubated at 37° C for 16 – 18 hours. 
After incubation period, the zone of inhibition around each disc was 
measured and the results were interpreted. 
 
READING AND INTERPRETATION OF RESULTS 
After 16 -18 hours of incubation, each plate was examined for 
satisfactory streaking with uniformly circular zones of inhibition and 
semi confluent lawn of growth. The diameter of the zones of complete 
inhibition including the diameter of the discs was measured. The zones 
were measured using zone scale that was held on the back by inverting 
Petri plate. The Petri plate was held a few inches above a black, non -
reflecting background and illuminated with reflected light. The zone 
margin showing no obvious visible growth that could be detected with 
unaided eyes was considered as the zone of inhibition . The sizes of the 
zones of inhibition were interpreted by referring to the CLSI standards 
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and reported as ‛Susceptible’, ‛Intermediate’ or ‛Resistant’ to the drugs 
that were tested. 
 
CONTROL STRAINS USED WITH EACH BATCH ARE 
 Escherichia coli   ATCC 25922 
 Pseudomonas aeruginosa  ATCC 27853 
 Staphylococcus aureus  ATCC 25923 
 
STATISTICAL ANALYSIS 
All statistical analysis were performed using SPSS version with     
(p value) p < 0.05 accepted as statistically significant. Univariate analysis 
was used to compare the relationship between age, gender, burn depth, 
total body surface burn area and positive results of quantitative biopsy 
versus surface swab cultures. The Chi-square test was used for 
categorical variables, and Student’s t-test was used for continuous 
variables. 
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TABLE 3 
ZONE SIZE INTERPRETATION CHART ACCORDING TO CLSI 
PRIMARY USE 
S.No Antimicrobial 
agent 
Symbol Disc 
conc 
(μg) 
           Zone size in mm 
Resistant IMS Sensitive 
1 Ampicillin AMP 10 <13 14-16 >17 
2 Erythromycin E 15 <13 14-22 >23 
3 Cotrimoxazole COT 1.25/ 
23.75 
<10 11-15 >16 
4 Gentamicin GEN 10 <12 13-14 >15 
5 Amikacin AK 30 <14 15-16 >17 
6 Ciprofloxacin CF 5 <15 16-20 >21 
7 Cephalexin CH 30 <14 15-17 >18 
8 Ceftrioxone CTR 30 <13 14-20 >21 
9 Cefoxitin CX 30 <14 15-17 >18 
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TABLE 4 
ZONE OF INTERPRETATION CHART ACCORDING TO CLSI 
PRIMARY BUT SELECTIVE DRUGS 
S.No Antimicrobial agent Symbol 
Discconc 
(μg) 
   Zone size in mm 
R IMS S 
1 Aztreonam AT 30 <15 16-21 >22 
2 Cefotaxime CTX 30 <14 15-22 >23 
3 Ceftazidime CAZ 30 <14 15-17 >18 
4 Doxycyclin DO 30 <12 13-15 >16 
5 Imipenem IPM 10 <13 14-15 >16 
6 Linezolid LZ 30 - - >21 
7 Ofloxacin OF 5 <12 13-15 >16 
8 Piperacillin/Tazobactum PIT 100/10 <17 18-20 >21 
9 Rifampicin RIF 5 <16 17-19 >20 
10 Tobramycin TOB 10 <12 13-14 >15 
11 Vancomycin VA 30 - - >15 
12 Ceftazidime/Clav CAC 30/10 - - - 
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TABLE 5 
ZONE OF INTERPRETATION CHART ACCORDING TO CLSI 
SUPPLEMENTAL OR RESERVE DRUGS 
S.No Antimicrobial agent Symbol 
Discconc 
(μg) 
   Zone size in mm 
R IMS S 
1 Chloramphenicol C 30 μg 12 13-17 18 
2 Cefepime CPM 30 μg 14 15-17 18 
3 Ticaricillin TI 75 μg 14 - 15 
4 Netilmycin NET 30 μg 12 13-14 15 
5 Meropenam MRP 10 μg 13 14-15 16 
6 Teicoplanin TEI 30 μg 10 11-13 14 
7 Rifampicin RIF 5 μg 16 17-19 20 
8 Levofloxacin LE 5 μg 15 16-18 19 
9 Moxifloxacin MO 5 μg 20 21-23 24 
10 Quinupristin / 
Dalfopristin 
RP 15 μg 15 16-18 19 
11 Ticarcillin  / 
Clavulanate 
TCC 75/10 μg 14 15-19 20 
12 Colistin CL 10 μg 10 - 11 
13 Polymyxin B PB 300 units 11 - 12 
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DETECTION OF RESISTANT ISOLATES 
 Multidrug resistant organisms include Methicillin resistant 
staphylococcus aureus (MRSA), Exdended spectrum beta lactamase 
(ESBL) producing Gram negative bacteria, MDR pseudomonas and 
MDR Acinetobacter. Detection of  multiple drug resistance organisms 
was done by various phenotypic methods approved by the CLSI103 
 
DETECTION OF EXTENDED SPECTRUM BETA LACTAMASE 
 Detection of ESBL was done by Phenotypic confirmation  test by 
double disk diffusion. This was done on Mueller Hinton agar with 0.5 
McFarland standard of the organism. Lawn culture of the organism was 
made. A Ceftazidime (30 μg) disc  and  Ceftazidime/Clavulanic acid  
(30μg/10μg)  are  both  kept  well  in contact with the agar surface. Plates 
were incubated at 37 ̊ C for 24 hours. A 5 mm increase in zone of 
inhibition for Ceftazidime/Clavulanic acid was confirmed as ESBL. 
 
DETECTION OF METALLO BETA LACTAMASES 
 Detection of  MBL was done by  Combined Disk Test using 
Imipenam (10μg) and Imipenam  EDTA (10/750μg). The test inoculum 
was prepared with an overnight growth of each isolate, which was 
adjusted to a turbidity equivalent to 0.5 McFarland standard. The test 
organism was inoculated  in MHA plate. The inoculum was allowed to 
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MBL – ACINETOBACTER BAUMANNII MBL – PSEUDOMONAS AERUGINOSA 
MRSA – STAPHYLOCOCCUS AUREUS MRSA – STAPHYLOCOCCUS AUREUS 
ESBL – KLEBSIELLA PNEUMONIAE ESBL – KLEBSIELLA PNEUMONIAE 
 
 
dry for 5 minutes with lid in place. Then the Imipenam and Imipenam 
EDTA discs kept on the agar and incubated at 37 ° C for 24 hours.The 
increase in inhibition zone with IMP -EDTA disc by more than 7mm over 
that of IMP is MBL positive. 
 
DETECTION OF METHICILLIN RESISTANT 
STAPHYLOCOCCUS AUREUS 
 Detection of MRSA is done by Cefoxitin disc diffusion test. 
Atleast three to five well isolated colonies of the same morphological 
type are selected from as agar plate culture. The top of each colony is 
touched with a loop, and the growth is transferred into a tube containing 4 
to 5 ml of a peptone water until it achieves the turbidity of the 0.5 
McFarland standard containing approximately 1 x 108 CFU/ml. A lawn 
culture was done on the Mueller-Hinton agar plate and a Cefoxitin disc of 
concentration 30 μg was kept in the centre and pressed well to ensure 
good contact to the agar surface. Plates were incubated at 37 ° C for 18-
24 hours and zone diameters measured. An inhibition zone diameter of    
<   19mm  was reported as oxacillin resistant and   >   20 mm was 
considered as oxacillin sensitive.   
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RESULTS  
 
 
RESULTS AND OBSERVATIONS 
 During the study period from June 2013 to July 2014, a total 
number of  83 surface swabs and 209 tissue biopsy samples were 
collected from 83 burn patients admitted in the burns ward at Thanjavur 
Medical College Hospital, Thanjavur. Both the surface swabs and the 
tissue biopsy specimens were processed in the 24 hours Microbiology 
Diagnostic Laboratory, Thanjavur Medical College Hospital. 
TABLE 6 
 AGE DISTRIBUTION 
Age No.of Cases 
(n=83) 
% 
<15 5 6.02 
16 – 30 43 51.81 
31 – 45 23 27.71 
46 – 60 11 13.25 
>60 1 1.20 
 
Among the total population ,the age and sex distribution were studied in  
burn wound infections. Out of 83 cases, the most common age group 
affected was 16-30 years (51.81%), followed by the age group 31-45 
years (27.71%). Least number of cases was seen in the age group of more 
than 60 years (1.20%).Table 6. 
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TABLE 7 
GENDER DISTRIBUTION 
 
 
 
 
 
Out of 83 cases, 45 cases were females (54.22%) and 38  cases were 
males  (45.78%). Table 7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Gender  No.of Cases 
(n=83) 
% 
Male 38 45.78 
Female 45 54.22 
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TABLE 8 
PREVALENCE OF TOTAL BODY SURFACE AREA BURNS 
 
TBSA burns No. of cases 
(n=83) 
Percentage 
10-20% 26 31.33 
21-30% 18 21.69 
31-40% 11 13.25 
41-50% 05 6.02 
51-60% 17 20.48 
61-70% 06 7.23 
 
                  The burn wound infections were studied in relation to extent 
of burns and degree of burns. The extent of burns is expressed as total 
body surface area burns (TBSA) and marked as percentage of burns. Out 
of 83 cases, 26 persons were between 10-20% TBSA burns (31.33%) 
followed by 18 cases between 21-30% TBSA burns (21.69%). 11 cases 
(13.25%) were between 31-40% TBSA burns,6 cases (7.23%) were 
between 61-70% TBSA burns,  and 17 cases (20.48%) were between 51-
60%. Least number of cases were between 41-50% TBSA burns ie 5 
cases (6.02%) Table 8 
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TABLE 9 
DISTRIBUTION OF DEGREE OF  BURNS. 
 
 
 
The burn wounds were studied according to the degree of burns attained 
depending upon the depth of skin involvement. Out of 83 cases, 35 cases 
had I degree burns (42.17%) followed by 26 cases who had III degree 
burns (31.32%) and 22 cases (26.51%) had II degree burns. Table 9 
 
 
 
 
 
 
Degree No.of Cases 
(n=83) 
% 
I 35 42.17 
II 22 26.51 
III 26 31.32 
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TABLE 10 
DISTRIBUTION OF ISOLATES BY GRAM STAINING 
 
Gram 
staining 
Swab 
culture 
(n=69) 
 
% 
Tissue biopsy 
culture  
(n=294) 
% 
Positive 45 65.22 128 43.54 
Negative 24 34.78 166 56.46 
 
The isolates were differentiated according to gram staining procedure into 
gram positive and gram negative organisms. The distribution of isolates 
by gram staining were compared between the swab culture isolates and 
the tissue culture isolates. Out 69 swab culture isolates, 45 samples 
(65.22%) were gram positive and 24 samples (34.78%) were gram 
negative. Out of 294 isolates obtained from the tissue biopsy culture, 128 
samples were gram positive (43.54%) and 166 samples were gram 
negative (56.46%). The surface swabbing showed gram positive 
predominance of organisms while in the tissue biopsy culture there was 
gram negative predominance. Table 10 
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TABLE 11 
CORRELATION BETWEEN SURFACE SWABBING AND 
TISSUE BIOPSY CULTURE 
Specimen Surface swab culture 
(n=83) 
% Tissue Biopsy culture  
(n=209) 
% 
Culture positive 51 61.45 199 95.22 
Culture negative 32 38.55 10 4.78 
 
 
Out of 83 surface swab cultures, 51 cases showed culture positive 
(61.45%) and 32 cases were culture negative (38.55%). Out of 209 tissue 
biopsy samples, 199 cases showed culture positive (95.22%) and 10 cases 
were culture negative (4.78%). (Table 11) 
 
 
 
 
 
 
 
 
 
67 
 
 
 
TABLE 12 
CULTURE POSITIVE AND NEGATIVE CASES IN TISSUE 
BIOPSY SPECIMENS 
 
Tissue Biopsy 
(n=209) 
Day 1 % Day 4 % Day 9 % 
Positive 74 89.16 69 98.57 56 100 
Negative 09 10.84 01 1.43 0 0 
Total 83  70  56  
 
In the tissue biopsy specimens, out of 83 samples taken on Day 1, 74 
sampleswere  culturepositive (89.16%), out of 70 samples taken on Day 
4, 69 samples were culture positive (98.57%) and out of 56 samples taken 
on Day 9, 56 samples were culture positive (100%). Table 12 
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TABLE 13 
PREVALENCE OF SINGLE AND MULTIPLE ISOLATES IN 
TISSUE BIOPSY 
 
No. of isolates Day 1 Day 4 Day 9 Total 
Single 45 33 20 98 
multiple 17 33 36 86 
 
Among the 294 isolates from the tissue biopsy specimens, 45 single 
isolates and 17 multiple isolates were found on  samples  taken on Day 1, 
33 single isolates and 33 multiple isolates from sample taken on Day 4, 
and 20 single isolates and 36 multiple isolates from sample taken  on  
Day 9.(Table 13) 
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TABLE 14 
PREVALENCE OF ORGANISMS IN SWAB CULTURE 
TECHNIQUE 
Isolates 
 
No.of isolates 
(n=92) 
percentage 
Staphylococcus aureus 28 30.43 
Pseudomonas aeruginosa 8 8.70 
Klebsiella pneumoniae 4 4.35 
Escherichia coli 3 3.26 
Acinetobacter baumanni 2 2.17 
Proteus mirabilis 4 4.35 
CoNS 13 14.13 
Klebsiella oxytoca 2 2.17 
Enterobacter aerogenes 1 1.09 
MRSA 4 4.35 
Micrococcus 7 7.61 
Diphtheroids 2 2.17 
No Growth 14 15.22 
 
In this study, surface swabbing showed Staphylococcus aureus (30.43%) 
was the commonest organism from the burn wounds followed by CoNS 
(14.13%), Pseudomonas aeruginosa (8.70%), Klebsiella pneumonia 
(4.35%), Proteus mirabilis (4.35%) and MRSA (4.35%), Escherichia coli 
(3.26%), Acinetobacter baumanni (2.17%), Klebsiella oxytoca (2.17%), 
Enterobacter aerogenes (1.09%). Micrococcus was isolated in 7 cases 
(7.61%). Diphtheroids was found in (2.17%). No growth was reported in 
15.22%. (Table 14) 
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TABLE 15 
PREVALENCE OF ORGANISMS IN TISSUE BIOPSY CULTURE 
Isolates 
No. of isolates (n=294) 
Total % 
Day 1 Day 4 Day 9 
Pseudomonas 
aeruginosa 
14 13 11 38 12.93 
Staphylococcus aureus 35 32 29 96 32.65 
MRSA 10 10 9 29 9.86 
Acinetobacter 
baumanni 
5 5 2 12 4.08 
Escherichia coli 9 20 23 52 17.69 
Klebsiella 
pneumoniae 
15 13 14 42 14.29 
Klebsiella oxytoca 2 3 1 6 2.04 
Citrobacter freundii 1 1 0 2 0.68 
Proteus mirabilis 4 4 3 11 3.74 
Enterobacter 
aerogenes 
1 1 1 3 1.02 
CoNS 1 1 1 3 1.02 
No Growth 9 1 0 10 0 
 
The predominant organism isolated in the tissue biopsy culture was 
Staphylococcus aureus 32.65% followed by Escherichia coli 17.69% and 
Klebsiella pneumonia 14.29%. Pseudomonas aeruginosa was 12.93%, 
MRSA was 9.86%, Acinetobacter baumanni was 4.08%, Klebsiella 
oxytoca 2.04%,Proteus mirabilis 3.74%, Citrobacter freundii 
0.68%,Enterobacter aerogenes 1.02%, CoNS was 1.02%. No growth was 
reported in 10 cases and was predominantly noted in the Day 1 sample (9 
cases) and I case was reported in Day 4 sample. (Table-15) 
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TABLE 16 
COMPARISON OF ISOLATES BY SWAB AND TISSUE BIOPSY 
CULTURES 
 
While comparing both the swab and tissue cultures, both showed 
predominance of Staphylococcus aureus. It should be noted that CoNS, 
Micrococci, Diphtheroids and culture negatives were  reported only 
in surface swabbing but not in tissue biopsy cultures. CoNS was 
isolated only in three cases. There were no Micrococci and Diphtheroids 
reported in the tissue biopsy cultures.Moreover, Klebsiella pneumonia 
and Escherchia coli were  more common colonizers in the tissue biopsy 
cultures. On comparison of 92 surface swab cultures and 294 tissue 
biopsy cultures,there was moderate concordance for Staphylococcus 
aureus, low concordance for of Klebsiella oxytoca, Enterobacter 
aerogenes, and Proteus mirabilis.(Table 16) 
organisms Swab culture 
(n=92) 
% Tissue biopsy 
(n=294) 
% 
Staphylococcus aureus 28 30.43 96 32.65 
Pseudomonas aeruginosa 8 8.70 38 12.93 
Klebsiella pneumoniae 4 4.35 42 14.29 
Escherichia coli 3 3.26 52 17.69 
Acinetobacter baumanni 2 2.17 12 4.08 
Proteus mirabilis 4 4.35 11 3.74 
CoNS 13 14.13 3 1.02 
Enterobacter aerogenes 1 1.09 3 1.02 
Klebsiella oxytoca 2 2.17 6 2.04 
MRSA 4 4.35 29 9.86 
Citrobacter freundii 0 0 2 0.68 
Micrococcus 7 7.61 0 0 
Diphtheroids 2 2.17 0 0 
No Growth 14 15.22 10 0 
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TABLE 17 
DISTRIBUTION OF MEAN BACTERIAL COUNTS OF THE 
ISOLATES 
Organisms No. of  
isolates 
Bacterial counts  
Mean  (ہ x 10P5 P) 
Staphylococcus aureus 96 4.40 
Pseudomonas aeruginosa 38 3.57 
Klebsiella pneumonia 42 1.11 
Escherichia coli 52 0.89 
MRSA 29 4.78 
Acinetobacter baumanni 12 1.75 
Proteus mirabilis 11 2.54 
Klebsiella oxytoca 6 0.54 
Citrobacter freundii 2 2.35 
Enterobacter aerogenes 3 2.40 
  
Out of the 294 isolates, the bacterial counts were calculated for each 
organism isolated. Among the isolates, Staphylococcus aureus (96) 
showed a mean bacterial count of 4.40 x 105, Pseudomonas aeruginosa 
(38) was 3.57 x 105, Klebsiella pneumonia (42) was 1.11 x 105, MRSA 
(29) was 4.78 x 105, Acinetobacter baumannii (12) was 1.74 x 105, 
Proteus mirabilis (11) was 2.54 x 105, Citrobacter freundii (2) was 2.35 x 
105,  and Enterobacter aerogenes (3) was 2.40 x 105. Eshcherichia coli 
(52) and Klebsiella oxytoca (6) showed  mean bacterial counts of 0.89  
and 0.54  respectively which was less than 105 CFU/gm of tissue.      
Table 17. 
. 
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TABLE 18 
CORRELATION BETWEEN BURN WOUND EXTENT AND 
BACTERIAL COUNTS 
 
TBSA burns No. of cases 
(n=83) 
Bacterial counts 
(mean) 
10-20% 26 2.13 
21-30% 17 2.64 
31-40% 11 3.54 
41-50% 6 3.49 
51-60% 17 2.73 
61-70% 6 2.79 
 
The mean bacterial counts were calculated in relation to the extent of 
burns and also to the degree of burns. The mean bacterial counts were 
higher in 31-40% TBSA burns (3.54) followed by 41-50% TBSA burns 
(3.49). The bacterial counts for 10-20% was 2.13, 21-30% was 2.64, 51-
60% was 2.73% and 61-70% was 2.79%. There was 26 cases with 10-
20% TBSA burns,17 cases with 21-30% and 51-60% TBSA burns, 11 
cases with 31-40% TBSA burns and 6 cases with 41-50% and 61-70% 
TBSA burns. (Table 18) 
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TABLE 19 
CORRELATION BETWEEN DEGREE OF BURNS AND 
BACTERIAL COUNTS 
 
Degree of burns 
 
No. of cases 
(n=83) 
Bacterial counts 
(Mean) 
I degree 35 2.21 
II degee 22 3.68 
III degree 26 2.88 
 
 
According to the degree of burns, 35 cases were with I degree burns, 22 
cases with II degree burns and 26 cases with III degree burns. The mean 
bacterial counts was higher in II degree burns  which was 3.68,  followed 
by III degree which was 2.88 and I degree with 2.21. (Table 19) 
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TABLE 20 
CHARACTERISTICS OF SURFACE AND BIOPSY CULTURE 
POSITIVE BURN PATIENTS 
Characteristics Cases 
                Mean + SD 
P 
value 
Surface culture 
positive cases 
Biopsy culture 
positive cases 
Age 
<15 5 3 5 
0.001 
16-30 43 22 42 
31-45 23 15 22 
46-60 11 8 9 
>60 1 1 1 
Gender 
Male 38 20 28 
0.02 
Female 45 20 33 
Burn 
depth 
I degree 35 18 18 
0.31 II degree 22 20 22 
III degree 26 25 26 
TBSA 
burns 
10 – 20% 26 12 25 
0.008 
21 – 30% 17 12 15 
31 – 40% 11 9 11 
41 – 50% 6 4 6 
51 – 60% 17 9 17 
61 – 70% 6 4 6 
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In the characteristic analysis, burn depth showed no significant 
association with the results of quantitative biopsy cultures. As for gender, 
there was significant association between the positive biopsy results and 
the female gender (p<0.05). Age group showed a significant association 
with the results of biopsy cultures with the age group between 16 – 30 
(p<0.05). There was significantly lower level of TBSA in patients with 
positive surface swab cultures compared with that biopsy cultures 
(p<0.05). (Table 20) 
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TABLE 21 
ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF 
STAPHYLOCOCCUS AUREUS 
Antimicrobials Staphylococcus aureus 
(n=96) 
Sensitive Percentage Resistant Percentage 
Ampicillin 3 3.13 93 96.87 
Erythromycin 22 22.92 74 77.08 
Vancomycin 96 100 0 0 
Gentamicin 80 83.33 16 16.67 
Amikacin 89 92.71 7 7.29 
Cotrimoxazole 41 42.71 55 57.29 
Cephalexin 0 0 96 100 
Ceftrioxone 47 4.17 49 95.83 
Ciprofloxacin 83 86.46 13 13.54 
Ofloxacin 94 97.92 2 2.08 
Linezolid 93 96.87 3 3.12 
Doxycyclin 89 92.71 7 7.29 
 
Antimicrobial susceptibility testing was carried out for all bacterial 
isolates as per CLSI guidelines by Kirby Bauer disk diffusion method. 
The antibiogram of Staphylococcus aureus showed sensitivity to 
Ampicillin (3.13%), Erythromycin (22.92%), Vancomycin (100%), 
Gentamicin (83.33%), Amikacin (92.71%), Cotrimoxazole (42.71%), 
Ceftrioxone (4.17%), Ciprofloxacin (86.46%), Ofloxacin (97.92%), 
Linezolid (96.87%) and Doxycyclin (92.71%). Total resistant patterns 
were noted in Cephelexin (100%) and relative resistant patterns were 
noted in Ampicillin (96.87%). Table 21 
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TABLE 22 
ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF MRSA 
 
The antibiogram of MRSA showed sensitivity to Erythromycin (10.34%), 
Vancomycin (93.10%), Gentamicin (68.97%), Amikacin (68.97%), 
Cotrimoxazole (51.72%), Ciprofloxacin (75.86%), Ofloxacin (96.55%), 
Linezolid (100%), Doxycyclin (96.55%). Total resistance were noted in 
Ampicillin, Cephalexin and Ceftriaxone. Table 22 
 
 
 
 
Antimicrobials MRSA 
(n=29) 
Sensitive Percentage Resistant percentage 
Ampicillin 0 0 29 100 
Erythromycin 3 10.34 26 89.66 
Vancomycin 27 93.10 2 6.90 
Gentamicin 20 68.97 9 31.03 
Amikacin 20 68.97 9 31.03 
Cotrimoxazole 15 51.72 14 48.28 
Cephalexin 0 0 29 100 
Ceftrioxone 0 0 29 100 
Ciprofloxacin 22 75.86 7 24.14 
Ofloxacin 28 96.55 1 3.45 
Linezolid 29 100 0 0 
Doxycyclin 28 96.55 1 3.45 
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TABLE 23 
ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF 
KLEBSIELLA PNEUMONIAE 
 
The antibiogram of Klebsiella pneumonia showed sensitivity to 
Piperacillin/Tazobactum (90.48%), Gentamicin (73.81%), 
Amikacin(92.86%), Tobramycin(47.62%), Cotrimoxazole(7.14%), 
Ciprofloxacin (35.71%), Ceftriaxone (28.57%), Cefotaxime(73.81%), 
Ceftazidime (69.05%), Aztreonam (33.33%), and Imipenam (97.62%) 
among 42 isolates. The antibiogram showed total resistance to Ampicillin 
and Cephalexin. (Table 23)  
 
   Organism 
 
 
Klebsiella pneumonia 
(n = 42) 
Sensitive Percentage Resistant Percentage 
Ampicillin 0 0 42 100 
Pip/Tazo 38 90.48 4 9.52 
Gentamicin  31 73.81 11 26.19 
Amikacin 39 92.86 3 7.14 
Tobramycin 20 47.62 22 52.38 
Cotrimoxazole 3 7.14 39 92.86 
Ciprofloxacin 15 35.71 27 64.29 
Cephalexin 0 0 42 100 
Ceftriaxone 12 28.57 30 71.43 
Cefotaxime 31 73.81 11 26.19 
Ceftazidime 29 69.05 13 30.95 
Aztreonam 14 33.33 28 66.67 
Imipenam 41 97.62 1 2.38 
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TABLE 24 
ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF 
ESCHERICHIA COLI 
 
The antibiogram of Escherichia coli showed sensitivity to 
Piperacillin/Tazobactum (80.77%), Gentamicin (82.69%), 
Amikacin(100%), Tobramycin(65.38%), Cotrimoxazole(21.15%), 
Ciprofloxacin (55.77%), Ceftriaxone (30.77%), Cefotaxime(55.77%), 
Ceftazidime (61.54%), Aztreonam (71.15%), and Imipenam (100%) 
among 52 isolates. The antibiogram showed total resistance to Ampicillin 
and Cephalexin. (Table 24)  
 
   Organism 
 
 
Escherichia coli 
(n = 52) 
Sensitive Percentage Resistant Percentage 
Ampicillin 0 0 52 100 
Pip/Tazo 42 80.77 10 19.23 
Gentamicin  43 82.69 9 17.31 
Amikacin 52 100 0 0 
Tobramycin 34 65.38 18 34.62 
Cotrimoxazole 11 21.15 41 78.85 
Ciprofloxacin 29 55.77 23 44.23 
Cephalexin 0 0 52 100 
Ceftriaxone 16 30.77 36 69.23 
Cefotaxime 29 55.77 23 44.23 
Ceftazidime 32 61.54 20 38.46 
Aztreonam 37 71.15 15 28.85 
Imipenam 52 100 0 0 
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TABLE 25 
ANTIMICROBIAL SENSITIVITY PATTERN OF PROTEUS MIRABILIS 
 
   Organism 
 
 
Proteus mirabilis 
(n = 11) 
Sensitive Percentage Resistant Percentage 
Ampicillin 0 0 11 100 
Pip/Tazo 11 100 0 0 
Gentamicin  6 54.55 5 45.45 
Amikacin 8 72.73 3 27.27 
Tobramycin 7 63.64 4 36.36 
Cotrimoxazole 0 0 11 100 
Ciprofloxacin 5 45.45 6 54.55 
Cephalexin 0 0 11 100 
Ceftriaxone 2 18.18 9 81.82 
Cefotaxime 7 63.64 4 36.36 
Ceftazidime 6 54.55 5 45.45 
Aztreonam 2 18.18 9 81.82 
Imipenam 11 100 0 0 
 
The antibiogram of Proteus mirabilis showed sensitivity to 
Piperacillin/Tazobactum (100%), Gentamicin (54.55%), 
Amikacin(72.73%), Tobramycin(63.64%), Ciprofloxacin (45.45%), 
Ceftriaxone (18.18%), Cefotaxime(63.64%), Ceftazidime (54.55%), 
Aztreonam (18.18%), and Imipenam (100%) among 11 isolates. The 
antibiogram showed total resistance to Ampicillin, Cotrimoxazole and 
Cephalexin. (Table 25) 
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TABLE 26 
ANTIMICROBIAL SENSITIVITY PATTERN OF 
CITROBACTER FREUNDII 
 
The antibiogram of Citrobacter freundii showed 100% sensitivity to 
Piperacillin/Tazobactum, Cefotaxime, Ceftazidime, Aztreonam and 
Imipenam and showed 50% sensitivity to Tobramycin among 2 isolates. 
Table 26 
 
 
 
 
   Organism 
 
 
Citrobacter freundii 
(n = 2) 
Sensitive Percentage Resistant Percentage 
Ampicillin 0 0 2 100 
Pip/Tazo 2 100 0 0 
Gentamicin  0 0 2 100 
Amikacin 0 0 2 100 
Tobramycin 1 50 1 50 
Cotrimoxazole 0 0 2 100 
Ciprofloxacin 0 0 2 100 
Cephalexin 0 0 2 100 
Ceftriaxone 0 0 2 100 
Cefotaxime 2 100 0 0 
Ceftazidime 2 100 0 0 
Aztreonam 2 100 0 0 
Imipenam 2 100 0 0 
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TABLE 27 
ANTIMICROBIAL SENSITIVITY PATTERN OF 
 KLEBSIELLA OXYTOCA 
 
The antibiogram of Klebsiella oxytoca showed 100% sensitivity to 
Piperacillin/Tazobactum, Gentamicin, Amikacin and Imipenam. It 
showed sensitivity to Tobramycin (66.67%), Cefotaxime (83.33%), 
Ceftazidime (50%), and Aztreonam (33.33%) among 6 isolates.        
(Table 27) 
 
 
 
   Organism 
 
 
Klebsiella oxytoca 
(n = 6) 
Sensitive Percenage Resistant Percentage 
Ampicillin 0 0 6 100 
Pip/Tazo 6 100 0 0 
Gentamicin  6 100 0 0 
Amikacin 6 100 0 0 
Tobramycin 4 66.67 2 33.33 
Cotrimoxazole 0 0 6 100 
Ciprofloxacin 0 0 6 100 
Cephalexin 0 0 6 100 
Ceftriaxone 0 0 6 100 
Cefotaxime 5 83.33 1 16.67 
Ceftazidime 3 50 3 50 
Aztreonam 2 33.33 4 66.67 
Imipenam 6 0 0 100 
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TABLE  28 
ANTIMICROBIAL SENSITIVITY PATTERN OF 
ENTEROBACTER AEROGENES 
 
   Organism 
 
 
Enterobacter aerogenes 
(n = 3) 
Sensitive Percentage Resistant Percentage 
Ampicillin 0 0 3 100 
Pip/Tazo 3 100 0 0 
Gentamicin  0 0 3 100 
Amikacin 3 100 0 0 
Tobramycin 1 33.33 2 66.67 
Cotrimoxazole 0 0 3 100 
Ciprofloxacin 0 0 3 100 
Cephalexin 0 0 3 100 
Ceftriaxone 0 0 3 100 
Cefotaxime 3 100 0 0 
Ceftazidime 1 33.33 2 66.67 
Aztreonam 3 100 0 0 
Imipenam 3 100 0 0 
 
The antibiogram of Enterobacter aerogenes showed 100% sensitivity to 
Piperacillin/Tazobactum, Amikacin, Cefotaxime, Aztreonam and 
Imipenam. It showed 33.33% sensitivity to tobramycin and Ceftazidime 
among 3 isolates.(Table 28) 
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TABLE  29 
ANTIMICROBIAL SENSITIVITY PATTERN OF 
PSEUDOMONAS AERUGINOSA 
 
The antibiogram of Pseudomonas aeruginosa showed sensitivity to 
Piperacillin/Tazobactum (78.95%), Gentamicin (57.89%), Amikacin 
(76.32%) Tobramycin (57.89%), Ciprofloxacin (13.16%),Ceftriaxone 
(39.47%),Cefotaxime (47.37%), Ceftazidime (60.53%), and Aztreonam 
(18.42%)  and Imipenam (81.59%) among 38 isolates. Total resistance 
pattern was noted in Ampicillin, Cotrimoxazole and Cephalexin. (Table  
29) 
 
Organism 
 
 
Pseudomonas aeruginosa 
(n = 38) 
Sensitive Percentage Resistant Percentage 
Ampicillin 0 0 38 100 
Pip/Tazo 30 78.95 8 21.05 
Gentamicin  22 57.89 16 42.11 
Amikacin 29 76.32 9 23.68 
Tobramycin 22 57.89 16 42.11 
Cotrimoxazole 0 0 38 100 
Ciprofloxacin 5 13.16 27 86.84 
Cephalexin 0 0 38 100 
Ceftriaxone 15 39.47 23 60.53 
Cefotaxime 18 47.37 20 52.63 
Ceftazidime 23 60.53 15 39.47 
Aztreonam 7 18.42 31 81.58 
Imipenam 31 81.58 7 18.42 
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TABLE 30 
ANTIMICROBIAL SENSITIVITY PATTERN OF 
ACINETOBACTER BAUMANNII 
 
The antibiogram of Acinetobacter baumannii showed sensitivity to 
Piperacillin/Tazobactum (25%), Amikacin (41.67%) Tobramycin (75%), 
Cefotaxime (66.67%), Ceftazidime (25%), and Aztreonam (25%)  and 
Imipenam (83.33%) among12 isolates. Total resistance pattern was noted 
in Ampicillin, Gentamicin, Cotrimoxazole ,Ciprofloxacin, Ceftriaxone 
and Cephalexin. Table 30. 
 
Organism 
 
 
Acinetobacter baumanni 
(n = 12) 
Sensitive Percentage Resistant Percentage 
Ampicillin 0 0 12 100 
Pip/Tazo 3 25 9 75 
Gentamicin  0 0 12 100 
Amikacin 5 41.67 7 58.33 
Tobramycin 9 75 3 25 
Cotrimoxazole 0 0 12 100 
Ciprofloxacin 0 0 12 100 
Cephalexin 0 0 12 100 
Ceftriaxone 0 0 12 100 
Cefotaxime 8 66.67 4 33.33 
Ceftazidime 3 25 9 75 
Aztreonam 3 25 9 75 
Imipenam 10 83.33 2 16.67 
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TABLE 31 
DISTRIBUTION OF MDR AMONG ISOLATES 
 
The distribution of MDR organisms were studied from all the 
microorganisms isolated. Among 294 isolates, there was 29 MRSA,  17 
ESBL producers and 14 MBL producers. Among 17 ESBL producers, 
Klebsiella pneumonia was 8, Klebsiella oxytoca was 3 and E.coli was 6. 
Among 14 MBL producers 7 were Pseudomonas aeruginosa and 7 were 
Acinetobacter baumanni.(Table 31) 
 
 
 
 
Organism No of 
isolates 
MDR 
MRSA ESBL MBL 
Staphylococcus aureus 125 29 - - 
Pseudo. aeruginosa 38 - - 7 
Acinet. baumanni 12 - - 7 
Klebsiella pneumoniae 42 - 8 - 
Klebsiella oxytoca 06 - 3 - 
Escherchia coli 52 - 6 - 
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TABLE 32 
CORRELATION BETWEEN BACTERIAL COUNTS AND CLINICAL OUTCOME 
S. 
No Age 
Gender 
 
 
Raw area 
% 
 Isolate 
Bacterial count Clinical 
intervention 
Graft uptake 
M F  
1 30  F 20 Staphylococcus aureus 5.09 SSG 60% 
2 16 M  20 Staphylococcus aureus 5.34 SSG 50% 
3 50 M  25 Pseudomonas aeruginosa 0.51 SSG 70% 
4 20 M  20 Klebsiella pneumoniae 0.30 SSG 95% 
5 48 M  30 - NG SSG 95% 
6 19 M  10 Pseudomonas aeruginosa Nil SSG 70% 
7 48 M  30 - NG SSG 100% 
8 50  F 30 Klebsiella pneumoniae 0.54 SSG 95% 
9 18  F 20 Staphylococcus aureus 6.54 SSG 60% 
10 18  F 20 Pseudomonas aeruginosa 1.80 SSG 60% 
11 22 M  30 - NG SSG 100% 
12 60 M  15 Staphylococcus aureus 4.13 SSG 50% 
Mean  33.5   22.5  2.18   
SD 16.48   6.57  2.67   
SEM 4.76   1.89  0.77   
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Out of 83 patients, this technique was employed in 12 burn patients 
whose raw areas were clinically ready for receiving skin graft . Tissue 
biopsy cultures and swab cultures were performed three days prior to the 
grafting procedures. Out of 12 patients, 8 patients were males and 4 
patients were females. Their ages vary from 16 years to 60 years and 
were in the mean age group of 33.50 with    SEM + 4.76. Their total body 
surface areas burnt vary from 10% to 30% with a mean raw area ranging 
between 22.50 with SEM  + 1.89. Their  bacterial counts ranged from 
0.30 x 105  to 6.54  x 105 with a  mean  bacterial count of 2.18 with SEM  
+   0.77.Staphylococcus aureus was isolated in 4 patients showed the 
highest bacterial counts. Pseudomonas aeruginosa was isolated in 3 
patients and the bacterial counts ranged from 0.51 to 1.80. Klebsiella 
pneumoniae was isolated in 2 patients and  their counts ranged from 0.30 
to 0.54. Split skin graft was planned  for all the patients. The “Graft 
Take″ for all the 12 patients were observed. Patients with bacterial counts 
ranging from 1.80 to 5.34 x 105  had a “graft take″ ranging from 50% to 
60%. Patients with bacterial counts from 0.30 to 0.51 x 105 had a  “graft 
take ” of 70% to 95%.Patients who were culture negative had a 95% to 
100%  “graft take”. (Table 32) 
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DISCUSSION 
 Infection in the burn wound continues to be the main cause of 
morbidity and mortality in patients who are admitted to hospital with 
major thermal burns.104 Burns provide a suitable site for bacterial 
multiplication and more persistent richer sources of infection mainly 
because of larger area of involvement and longer duration of stay of the 
patients in the hospital.105 Quantitative bacterial assay have been 
employed in this study to effectively monitor the burn wounds and to 
predict and prevent invasive burn wound sepsis  at an early stage. Tissue 
biopsy samples have been taken and quantitative bacteriology was 
performed and also quantitative bacterial assay was  compared with that 
of surface swabbing as it is the the chief modality of investigation in most 
of tertiary care centres. 
 In this study a total of  209 tissue biopsy samples and 83 surface 
swabs were collected from 83 burn wound patients admitted in burns 
ward. Tissue biopsy specimens were  homogenized in a Lab Blender 
Stomacher  80, several dilutions were made and then processed 
simultaneously with that of surface swab cultures. 
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AGE AND GENDER PREVALENCE OF BURN WOUND 
INFECTIONS 
 Out of 83 cases, burn wound infections were most common in 16-
30 age group (51.81%) followed by 31-40 age group (27.71%). Among 
the 83 patients, 45(54.22%) female and 38 (45.78%) were male  affected 
by burn wound infections. 
 
EXTENT OF  BURN WOUND INFECTIONS 
 Out of 83 cases, 26 cases (31.33%) acquired 10-20% TBSA burns 
followed by 18 cases (21.69%) between 21-30% TBSA burns. Least 
number of cases were between 41-50% TBSA burns ie 5 cases (6.02%) . 
The burn wounds were  studied according to the degree of burns  
depending upon the depth of skin involvement. Out of 83 cases, 35 cases 
had I degree burns (42.17%) followed by 26 cases who had III degree 
burns (31.32%). 
PREVALENCE OF ISOLATES BY GRAM STAINING 
Out 69 swab culture isolates, 45 samples (65.22%) were gram 
positive and 24 samples (34.78%) were gram negative. Out of 294 
isolates obtained from the tissue biopsy culture, 128 samples were gram 
positive (43.54%) and 166 samples were gram negative (56.46%). The 
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surface swabbing showed gram positive predominance of organisms. 
Eventhough  in tissue biopsy culture there was gram negative 
predominance, the most common isolate was Staphylococcus aureus. 
Various studies from routine burn wound culture surveillance at Boston 
displays a shift from gram negative to gram positive organisms and 
concluded that the most prevalent organisms are Methicillin sensitive 
Staphylococcus aureus.106McManus etal in his study stated that there was 
decrease in gram negative infections with improved isolation of burn 
patients.VG Bhat and SD Vasaikar substanstiated in their study107 that the 
most common isolate was gram positive organism namely 
Staphylococcus aureus.Two Brazilian studies namely Macedo JLS et al108 
and Santucci SG et al109 and one Malawi study namely Liwimbi et al110 
found Staphylococcus aureus as the predominant organism. On the other 
hand, two Nigerian studies namely Ozumba et al111 and Kehinde et 
al112showed Klebsiella as the commonest organism. Two Indian studies 
namely Singh et al113 and Kaushik R et al114 showed Pseudomonas as the 
predominant organism. 
SENSITIVITY OF TISSUE BIOPSY CULTURES AND SURFACE 
SWABBING CULTURES 
Out of 83 surface swab cultures, 51 cases showed culture positive 
(61.45%) and 32 cases were culture negative (38.55%). Out of 209 tissue 
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biopsy samples, 199 cases showed culture positive (95.22%) and 10 cases 
were culture negative (4.78%). The tissue biopsy samples were taken on 
Days 1, 4 and 9. In the tissue biopsy specimens, out of 83 samples taken 
on Day 1, 74 cultures were positive (89.16%), out of 70 samples taken on 
Day 4, 69 cultures were positive (98.57%) and out of 56 samples taken on 
Day 9, 56 samples were culture positive (100%). It should be noted that 
100% culture positives were present on Day 9 of tissue biopsy cultures. 
Moreover tissue biopsy cultures showed 95.22% culture positives  
whencompared with 61.45% culture positives in surface swabbing and 
cultures negatives were only 4.78% when compared to 38.55% of culture 
negatives in surface swabbing. This is a good evidence to show that tissue 
biopsy cultures are superior to surface swabbing. 
 Among the 294 isolates from the tissue biopsy specimens, 45 
single isolates and 17 multiple isolates were found on  samples  taken on 
Day 1, 33 single isolates and 33 multiple isolates from sample taken on 
Day 4, and 20 single isolates and 36 multiple isolates from sample taken  
on Day 9. There was more prevalence of multiple isolates on Day 9 
samples of tissue biopsy. 
PREVALENCE OF ORGANISMS IN BURN WOUNDS 
Surface swabbing showed Staphylococcus aureus (30.43%) was 
the commonest organism from the burn wounds followed by CoNS 
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(14.13%). The predominant organism isolated in the tissue biopsy culture 
was Staphylococcus aureus 32.65% followed by Escherichia coli 17.69% 
and Klebsiella pneumonia 14.29%. In surface swabbing, CoNS was 
reported in 14.13% and in many instances was reported as normal flora 
on clinical correlation. In case of tissue biopsy cultures only three isolates 
were reported as CoNS and were found to be sensitive to many drugs. 
More number of normal flora was also reported in surface swabbing such 
as Micrococcus, Diphtheroids and negative cultures were reported in 
15.22% cases. But tissue biopsy cultures reflected  the exact 
microorganism that existed in the sub eschar tissue at that period of time 
so that timely prediction and intervention may prevent mortality on a 
large basis.  
Comparison of swab and tissue biopsy cultures also revealed a 
moderate concordance in detection of Staphylococcus aureus, low 
concordance in detection of Klebsiella oxytoca, Enterobacter aerogenes, 
and Proteus mirabilis. 
QUANTIFICATION OF MICROORGANISMS 
Out of the 294 isolates, Staphylococcus aureus (96) showed a mean 
bacterial count of 4.40 x 105, Pseudomonas aeruginosa (38) was 3.57 x 
105, Klebsiella pneumonia (42) was 1.11 x 105, MRSA (29) was 4.78 x 
105, Acinetobacter baumannii (12) was 1.74 x 105, Proteus mirabilis (11) 
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was 2.54 x 105, Citrobacter freundii (2) was 2.35 x 105,  and Enterobacter 
aerogenes (3) was 2.40 x 105. Escherichia coli (52) and Klebsiella 
oxytoca (6) showed  mean bacterial counts of 0.89 x 105  and 0.54 x 105  
respectively which was less than 105 CFU/gm of tissue. 
More than 105 organisms were found with Staphylococcus aureus, 
Klebsiella pneumonia, Pseudomonas aeruginosa, MRSA, Acinetobacter 
baumanni, Proteus mirabilis, Citrobacter freundii and Enterobacter 
aerogenes. Escherichia coli and Klebsiella oxytoca  showed  mean 
bacterial counts  less than 105 CFU/gm of tissue and  was considered as 
colonizers. 
CORRELATION BETWEEN DEGREE AND BURN EXTENT AND 
BACTERIAL COUNTS 
 Bacterial counts were more than 105 regardless of extent and 
degree of burns but were 3.49 x 105 in 41-50%  and  3.54 x 105 in 31-40% 
TBSA burns. It was 3.68 x 105 in II degree burns. 
CHARACTERISTICS OF SURFACE AND BIOPSY CULTURE 
POSITIVE BURN PATIENTS 
 In the analysis, burn depth showed no significant association with 
the results of quantitative biopsy cultures. As for gender, there was 
significant association between the positive biopsy results and the female 
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gender (p<0.05). Age group showed a significant association with the 
results of biopsy cultures with the age group between 16 – 30 (p<0.05). 
There was significantly lower level of TBSA in patients with positive 
surface swab cultures compared with that biopsy cultures (p<0.05). 
ANTIMICROBIAL SUSCEPTIBILITY TESTING 
Staphylococcus aureus showed sensitivity to Vancomycin (100%), 
Gentamicin (83.33%), Amikacin (92.71%), Cotrimoxazole (42.71%), 
Ciprofloxacin (86.46%), Ofloxacin (97.92%), Linezolid (96.87%) and 
Doxycyclin (92.71%). Total resistant patterns were noted in Cephelexin 
(100%) and relative resistant patterns were noted in Ampicillin 
(96.87%).The antibiogram of MRSA showed sensitivity to Erythromycin 
(10.34%), Vancomycin (93.10%), Gentamicin (68.97%), Amikacin 
(68.97%), Cotrimoxazole (51.72%), Ciprofloxacin (75.86%), Ofloxacin 
(96.55%), Linezolid (100%), Doxycyclin (96.55%). Total resistance were 
noted in Ampicillin, Cephalexin and Ceftrioxone. It should be noted that 
both Staphylococcus and MRSA showed good sensitivity pattern towards 
Cotrimoxazole and relative resistance was observed towards 
Cephalosporins and Penicillins. 
Among the Enterobacteriaceae family, Klebsiella pneumonia was 
sensitive to Piperacillin/Tazobactum (90.48%), Gentamicin (73.81%), 
Amikacin(92.86%), Tobramycin(47.62%), Ciprofloxacin (35.71%), 
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Cefotaxime(73.81%), Ceftazidime (69.05%), Aztreonam (33.33%), and 
Imipenam (97.62%) among 42 isolates. The antibiogram of Escherichia 
coli showed sensitivity to Piperacillin/Tazobactum (80.77%), Gentamicin 
(82.69%), Amikacin(100%), Tobramycin(65.38%), Ciprofloxacin 
(55.77%), Ceftriaxone (30.77%), Cefotaxime(55.77%), Ceftazidime 
(61.54%), Aztreonam (71.15%), and Imipenam (100%) among 52 
isolates. The antibiogram of Proteus mirabilis showed sensitivity to 
Piperacillin/Tazobactum (100%), Gentamicin (54.55%), 
Amikacin(72.73%), Tobramycin(63.64%), Ciprofloxacin (45.45%), 
Ceftriaxone (18.18%), Cefotaxime(63.64%), Ceftazidime (54.55%), and 
Imipenam (100%) among 11 isolates. The antibiogram of Citrobacter 
freundii showed 100% sensitivity to Piperacillin/Tazobactum, 
Cefotaxime, Ceftazidime, Aztreonam and Imipenem and showed 50% 
sensitivity to Tobramycin among 2 isolates. The antibiogram of 
Klebsiella oxytoca showed 100% sensitivity to Piperacillin/Tazobactum, 
Gentamicin, Amikacin and Imipenam. It showed sensitivity to 
Tobramycin (66.67%), Cefotaxime (83.33%), Ceftazidime (50%), and 
Aztreonam (33.33%) among 6 isolates. The antibiogram of Enterobacter 
aerogenes showed 100% sensitivity to Piperacillin/Tazobactum, 
Amikacin, Cefotaxime, Aztreonam and Imipenem. It showed 33.33% 
sensitivity to tobramycin and Ceftazidime among 3 isolates. In this study 
members of Enterobactericeae family was resistant to Ampicillin, most of 
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Cephalosporins and Cotrimoxazole. Proteus showed relative resistance to 
Aztreonam (81.82%). 
 The antibiogram of Pseudomonas aeruginosa showed sensitivity to 
Piperacillin/Tazobactum (78.95%), Gentamicin (57.89%), Amikacin 
(76.32%) Tobramycin (57.89%), Ceftriaxone (39.47%),Cefotaxime 
(47.37%), Ceftazidime (60.53%), and Imipenam (81.59%) among 38 
isolates. Total resistance pattern was noted in Ampicillin, Cotrimoxazole 
and Cephalexin and relative resistance to ciprofloxacin and Aztreonam. 
The antibiogram of Acinetobacter baumannii showed sensitivity to 
Amikacin (41.67%) Tobramycin (75%), Cefotaxime (66.67%), and  
Imipenem (83.33%) among 12 isolates. Total resistance pattern was noted 
in Ampicillin, Gentamicin, Cotrimoxazole ,Ciprofloxacin, Ceftriaxone 
and Cephalexin and relative resistance toPiperacillin/Tazobactum, 
Ceftazidime and Aztreonam. 
DISTRIBUTION OF MULTI DRUG RESISTANCE ORGANISMS 
 Among 294 isolates, there was 29 MRSA, 2 VRSA, 17 ESBL 
producers and 14 MBL producers. Among 17 ESBL producers, 
Klebsiella pneumonia was 8, Klebsiella oxytoca was 3 and E.coli was 6. 
Among 14 MBL producers 7 were Pseudomonas aeruginosa and 7 were 
Acinetobacter baumanni. 
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CORRELATION BETWEEN BACTERIAL COUNTS AND 
CLINICAL OUTCOME 
 Out of 83 patients, 12 patients who had raw areas which were 
ready to be grafted were chosen and studied prospectively. Tissue biopsy 
cultures were performed three days prior to the grafting procedures. Out 
of 12 patients, 8 patients were males and 4 patients were females. Their 
mean age vary from 16 years to 60 years and were in the mean age group 
of  33.50  with    SEM + 4.76. Their total body surface areas burnt vary 
from 10% to 30% with a mean raw area ranging  between  22.50 with   
SEM  + 1.89.  Their   bacterial counts ranged from 0.30 x 105  to 6.54  x 
105 with a  mean  bacterial count of 2.18 with SEM  +   0.77. The graft 
take was 95%-100% when the bacterial counts were less than 105 
CFU/gm of tissue. But when the bacterial counts exceeded 105 CFU/gm 
of tissue, the efficacy of  the  clinical outcome decreased as was 
evidenced by the poor uptake of the graft, even when the clinical 
interventional procedures were carried out under good antibiotic 
coverage. 
 Steer and colleagues88, in their study made a comparison between 
qualitative results and quantitative bacterial counts and concluded that the 
use of quantitative microbiology in burns is limited by the unreliability of 
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a single surface swab or biopsy sample to represent the whole burn 
wound.  
Steer and coworkers87 performed a clinical outcome study to 
determine the relationship between bacterial counts obtained by burn 
wound biopsy culture and surface swabs. Through their study they 
demonstrated that quantitative bacteriology by burn wound biopsy or 
surface swab sample does not aid the prediction of sepsis or graft loss. 
Loebl and colleagues82,85, demonstrated that the recovery of 
bacterial flora from the unexcised burn wound surface showed poor 
correlation with that from the tissue biopsy samples taken from deep sites 
beneath the eschar. 
Freshwater and Su79, also found that the results of quantitative burn 
wound cultures needed to be interpreted in conjunction with the clinical 
observations of burn wound infections in order to be a useful guide to the 
management of burn patients with large TBSA burns. 
Tahlan and colleagues83,in a study comparing surface swabs and 
burn wound biopsy cultures, found no difference in the types of 
microorganisms cultured from swabs versus those cultured from biopsies 
Levine and colleagues16, noted a linear numerical relationship 
between quantitative surface swab and biopsy sample counts of viable 
101 
 
 
 
bacteria from burn wounds, whereby counts of 105 bacteria per gram of 
biopsy sample were equated with counts of 106 bacteria obtained from 
surface swab samples. 
McManus and colleagues 80 ,found that quantitative cultures of 
tissue biopsy samples provided a better determination of the predominant 
bacterial types present in the burn wound. 
Herruzo-Cabrera and colleagues89, showed that a semiquantitative 
surface swab method distinguished between wound contamination and 
infection, using 105 organisms/gram as a threshold for the definition of 
infection by biopsy. 
Sjorberg and colleagues86, reported that quantitative tissue biopsies 
gave a better prediction of sepsis than surface swabs but concluded that 
the amount of labour involved in collection  and analysis of multiple 
biopsy samples limited the clinical relevance of this approach. 
Bharadwaj and colleagues26also assessed the value of blood 
cultures in the diagnosis of burn wound sepsis compared to burn wound 
cultures by either swab or tissue biopsy. They concluded that blood 
cultures were found to be of only prognostic value in this study.Blood 
cultures have also been shown to be a late sign of invasive burn wound 
infection even when they are positive.115 
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Mohammad Ashraf Ganatra and colleagues,100 in their study of 
method of quantitative  bacterial count in burn wound, described the 
technique for conducting quantitative bacteriology in burn wounds and 
concluded that quantitative bacteriology is simple  and easily adaptable 
and should be employed as the chief investigative tool for monitoring the 
bacterial count reaching the critical level of 105 per gram of tissue in 
every burn care unit. 
STRENGTH OF THE STUDY 
 Samples were collected, homogenized, quantitative bacterial assay 
done and processed by the same person, thereby eliminating the 
technical bias. 
 Uniform and strict criteria were followed for case selection. 
 Processing was done without delay in the shortest possible time. 
LIMITATIONS OF THE STUDY 
 Fungal isolates were not studied due to technical constraints. 
 Anaerobic work up was not done due to the same reason 
 Study population is limited to a single centre 
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SUGGESTIONS 
 Most common cause of mortality in burn patients are inhalation injury 
and systemic sepsis. All parameters should be taken care off to prevent 
impending sepsis. 
 To prevent transmission of exogenous organisms to patients  
 To control the transfer of endogenous organisms (normal flora) to 
sites at increased risk of infection 
 To protect and support existing defences in patients with seriously 
impaired resistance 
 To prevent dispersing of organisms into surrounding environment 
which is directly related to the percentage of burn injury 
 Standard precautions and strict aseptic protocol in all burn centres 
 Self-contained isolation rooms with separate burns bath  facility 
 Hand wash before and after each contact with the patient 
 Appropriate garbs, aprons, masks and gloves 
 Gloves changed after contamination with secretions and before 
contact with another patient 
 Sterile practice when caring for an open wound and while 
preparing for performing sterile procedures 
 Frequent decontamination of equipments, materials and surfaces 
in the burn unit 
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 Appropriate disinfection and sterilization procedures in the burn 
unit 
 Appropriate disposal of waste encountered in the burn wounds 
  Patient care items and equipments should be used according to 
CDC guidelines116 Critical items should be sterile. Semi-critical 
items should undergo high level disinfection to kill all organisms 
except spores. Noncritical items which is an effective barrier to 
most organisms and represent little risk of transmission of 
infection. 
 Routine surveillance of the burn patients is a must to allow early 
identification of organisms colonizing the wound  
 To detect cross colonization quickly when it occurs to prevent 
further transmission  
 To monitor the effectiveness of current wound treament strategies 
 To guide perioperative or empiric antibiotic therapy 
 Burn wound cultures by quantitative assays 
 Bacterial counts more than 10
5
 CFU/gm tissue is an indication of 
burn wound infection and alarming signal for excision of  
expedient eschar excision rather than starting antibiotics  
 Aiming early eschar excision and skin grafting as it prevents burn 
wound colonization 
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 Surveillance of environmental pathogens to prevent noscomial 
infection 
 Surveillance to prevent other complications like UTI, Pneumonia, 
and septicemia 
 Monitoring of fungal pathogens especially in prolonged hospital 
stay. 
 Prevention of injudicious use of antimicrobials as it leads to 
MDRO 
 Recognition of resistant strains of organisms  
 Always combination of topical and systemic antimicrobials should 
be attempted 
 Each antimicrobial must be selected based on its effect and its 
specificity for the microbe present 
 Decisions should be made on the basis of the culture and 
susceptibility data 
 Drug selection should be according to the CLSI guidelines and 
should be separated into three categories such as primary use, 
selective use and reserve drugs 
 The time, dosage, route of administration and duration of 
treatment should be in accordance with what is required in order 
to make the organism powerless 
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 Consideration should be given to local and systemic host resistant 
factors 
 With these measures there would be reduction of  mortality in 
burn wounds which at present is very high in India. 
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SUMMARY 
 The study was conducted at Thanjavur Medical College Hospital, 
Thanjavur over a period of June 2013 to July 2014. The study was 
conducted on 83 burn patients admitted here and samples consisting of 
both surface swab and tissue biopsy specimens were collected under strict 
aseptic procedures. The surface swabs were promptly processed. The 
tissue biopsy samples were homogenized in a homogenizer bag 
containing 1ml normal saline by Lab Blender Stomacher 80 for 
30seconds.Then several dilutions were made out of the homogenate and 
inoculated in Blood agar plates and MacConkey agar plates. Colonies 
were counted and the effective bacterial counts obtained by the formula. 
Processing was done and the isolates were identified by appropriate 
biochemical reactions. Antimicrobial susceptibility testing was done for 
both the surface swabs and the tissue biopsy samples. Each isolate were 
screened for drug resistance. The study showed the following results. 
 Out of 83 cases, 54.22% were females and 45.78% were males 
 Out of 83 cases 51.81% of  burn wounds were common in16-30 
age group and 27.71% between 31-45 age group 
 Out of 83 cases, 31.33% patients attained 10-20% TBSA burns and 
21.69% attained 21-30% TBSA burns 
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 Out of 83 cases, 42.17% of patients acquired I degree burns, 
31.32% III degree burns and 26.51% II degree burns 
 Out of 69 isolates in surface swabbing cultures, 65.22% were gram 
positive and 34.78% were gram negative. Out of 294 isolates in 
tissue biopsy cultures, 43.54% were gram positive and 56.46% 
were gram negative. 
 Out of 83 surface swab cultures, 61.45% were culture positive and 
38.55% were culture negative. Out of 209 tissue biopsy cultures, 
95.22% were culture positive and only 4.78% were culture 
negative. 
 Out of 209 tissue biopsy cultures, 89.16% were culture positive on 
Day I, 98.57% were positive on Day 4 and 100% were culture 
positive on Day 9. 
 Out of 294 isolates, 45 single isolates and 17 multiple isolates were 
present on Day1, 33 single isolates and 33 multiple isolate were 
present on day 4 and 20 single isolates and 36 multiple isolates 
were present on day 9. 
 Out of 92 isolates in swab cultures, the predominant isolate was 
Staphylococcus aureus forming 30.43%. More CoNS, 
Micrococcus, Diphtheroids and culture negatives  were reported in 
swab cultures. 
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 Out of 294 isolates in tissue biopsy isolates, Staphylococcus aureus 
was the predominant organism forming 32.65%. Less no of culture 
negatives and no normal flora was reported. 
 On comparison of 92 surface swab cultures and 294 tissue biopsy 
cultures,there was moderate concordance for Staphylococcus 
aureus, low concordance for of Klebsiella oxytoca, Enterobacter 
aerogenes, and Proteus mirabilis. 
 The mean bacterial counts were more than 105 organisms per gram 
of tissue for Staphylococcus aureus, Pseudomonas aeruginosa, 
Klebsiella pneumonia, MRSA, Acinetobacter baumanni, Proteus 
mirabilis, Citrobacter freundii abd Enterobacter aerogenes. The 
mean bacterial counts were less than 105 for E.coli and Klebsiella 
oxytoca and were considered to be colonizers. 
 Correlation between burn wound extent and bacterial counts 
showed than in all percentage of TBSA burns the bacterial count 
exceeded 105. Similarly correlation between degree of burns and 
bacterial counts showed counts more than 105. 
 There was significant association between positive biopsy results 
and the female gender (p<0.05), significant association between 
results of biopsy cultures and the age group between 16-30(p<0.05) 
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and significant association between lower levels of TBSA in 
patients with positive surface swab cultures.(p<0.05). 
 Staphylococcus and MRSA were mostly sensitive to Vancomycin, 
Gentamicin, Amikacin, Ciprofloxacin,Cotrimoxazole,Ofloxacin 
,Linezolid and Doxycyclin. They were resistant to Ampicillin, 
Cephalexin and Ceftriaxone. 
 The Enteric group of organisms were mostly sensitive to 
Piperacillin/Tazobactum,Gentamicin, Amikacin,Tobramycin, 
Ciprofloxacin, Cefotaxime, Ceftazidime, Aztreonam, and 
Imipenam . They were  resistant to Ampicillin, Ceftriaxone and 
Cephalexin. Only Proteus mirabilis showed relative resistance to 
Aztreonam. 
 Pseudomonas aeruginosa was mostly sensitive to 
Piperacillin/Tazobactum,Genamicin,Amikacin,Tobramycin,Ceftazi
dime and Imipenam, less sensitive to Ceftriaxone, 
Cefotaxime,Ciprofloxacin and Aztreonam.They were resistant to 
Ampicillin, Cotrimoxazole and Cephalexin. 
 Acinetobacter baumannii was sensitive to Tobramycin , 
Cefotaxime , and Imipenam.  They were less sensitive to 
Piperacillin/Tazobactum, Amikacin, Ceftazidime and Aztreonam. 
They were resistant toAmpicillin, Gentamicin, Cotrimoxazole 
,Ciprofloxacin, Ceftriaxone and Cephalexin. 
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 Distribution of MDR were found to be 29 MRSA, 17 ESBL 
producers and 14 MBL producers 
 12 burn patients whose  raw areas  were clinically ready for 
receiving skin graft were studied prospectively to know the clinical 
outcome. The graft take was 95%-100% when the bacterial counts 
were less than 105 CFU/gm of tissue. But when the bacterial counts 
exceeded 105 CFU/gm of tissue, the efficacy of the  clinical 
outcome decreased as was evidenced by the poor uptake of the 
graft, even when the clinical interventional procedures were carried 
out under good antibiotic coverage. 
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CONCLUSION 
 Quantitative bacteriology of the burn wound should be the main 
investigative tool for monitoring the  burn wound infections in order to 
prevent bacterial count reaching the critical level of 105 bacteria per gram 
of tissue. Staphylococcus aureus was the predominant organism isolated 
with bacterial counts more than 105 per gram of tissue. Comparison of the 
tissue biopsy with that of surface swabbing proved that quantitative 
bacteriology reflected the exact microbial load  in the subeschar tissue 
with bacterial counts exceeding  105  bacteria per gram of tissue for most 
of the organisms, while surface swabbing did not reflect the exact 
pathogen status. In this study, quantitative bacteriology proved very 
useful in surgical intervention by reduction of the microbial load by 
debridement and skin grafting, provided that the graft bed contains less 
than 105 bacteria per gram of tissue. When colony counts were less than 
102, graft survival was greater than 90%, but when colony counts were 
greater than 105, only a 60% graft survival rate was observed. On the 
basis of quantitative bacteriology, an effective antimicrobial battery of 
drugs has been formulated, specific  to this hospital and community 
environment. Each antimicrobials can be selected based on its effect and 
specificity for that microbe present, as quantitative bacteriology 
eliminates the contaminants and commensals and focuses on the 
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identification of the specific organism. Serial quantitative bacterial counts 
helps to alert the clinician about the evolution of colonizers to critical 
levels and hence decide about timely surgical intervention such as 
escharectomy, consequently preventing the onset of 
septicaemia.Distribution of MDRorganisms from the burn wound isolates 
were identified and an effective antibiotic policy has been formulated. 
Judicious use of third generation  Cephalosporins with appropriate MIC 
for Ceftazidime, Ceftriaxone,Cefotaxime will take care of the MDR 
organisms. Increase degrees of susceptibility to cotrimoxazole among the 
gram positive isolates including MRSA and some gram negative isolates 
suggest adequate “antibiotic holidays” can be allowed to those drugs 
which suffer extensive resistance like Ampicillin, Erythromycin and 
Cephalexin for a short course of time.  This study has proved that 
quantitative cultures obtained on a routine basis will monitor the progress 
of bacterial colonization, provide guidance in empirical antibiotic therapy 
and also allow prompt intervention against bacterial invasion. Here, the 
method described in this study is simple and easily adaptable. So it is 
recommended that it should be employed in every public and private burn 
care units all over India. 
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ANNEXURES 
 INFORMED CONSENT 
I have been informed about the study of Burn wound infections. I 
totally agree to participate in this study, as I realize the importance of the 
study. I am also aware that I can withdraw from the study whenever I 
want.  
 
 
 
Date:                                                                        Signature of the patient 
Department: 
 
 
 
 
 
 
 
 
 
 
 
 
 BURNS WOUND CASE HISTORY 
 
Name             :                                                              IP No/OP No     :    
Age/Sex          :        Ward          : 
Address          :       Central Lab No    : 
Occupation    :       Micro No              : 
Diagnosis        :     Date of sample collection: 
 
Chief Complaints: 
Nature of injury : 
Onset of injury   : 
Total area of burns: 
Breathlessness  : 
Fever    : 
Altered consciousness: 
Urine output: 
Past History: 
Treatment History: 
Diabetes: 
Hypertension: 
Personal History: 
 
Smoker :  Alcoholic:  Menstrual: 
Clinical diagnosis and treatment plan: 
 
 WORKSHEET 
Specimen : Pus,aspirate 
Method of collection  : Deep swabbing, Aspiration, Curetting 
I. Macroscopic Examination : Consistency, Presence of blood, Colour, 
Odour 
II. Microscopic Examination : Direst gram staining 
III. Culture     
       Nutrient agar  :  
      MacConkey agar :  
       Blood agar :  
      Gram staining                :  
      Motility :  
IV. Biochemical Reactions   
      Catalase :  
      Oxidase :  
      Sugar fermentation tests :  
      IMViC  :  
      Urease  :  
      TSI :  
      LAO  :       Special Tests: 
      Coagulase :  
      Micro organism isolated :  
V. Anti Microbial Susceptibility          
test 
: Antibiogram on MHA by Kirby Bauyer    
method 
 ANTIBIOGRAM 
 
S.No               DRUG A B C Remarks 
1.  Ampicillin     
2.  Amoxycillin     
3.  Amoxyclav     
4.  Oxacillin     
5.  Erythromycin     
6.  Azithromycin     
7.  Cotimoxazole     
8.  Doxycycline     
9.  Amikacin     
10.  Gentamicin     
11.  Ciprofloxacin     
12.  Ofloxacin     
13.  Cephelexin     
14.  Cefixime     
15.  Cefotaxime     
16.  Ceftrioxone     
17.  Ceftazidime     
18.  Ceftazidime+clav     
19.  Cefipime     
20.  Piperacillin+Tazo     
21.  Aztreonam     
22.  Imipenam     
23.  Vancomycin     
 
QUANTITATIVE BACTERIALASSAY 
 
1/10 
 
 
1/100 
1/1000 1/10000 
 
 
 
 
 
 
1/10 
 
 
1/100 
1/1000 
 
 
1/10000 
 
 
 
1/10 
 
 
1/100 
1/1000 
 
 
1/10000 
 
 
 
 
 
 
 
 
 
 
Day 1 Weight of tissue 
Isolate Colony count 
1  
 
 
2  
 
 
Day 2 Weight of tissue 
Isolate Colony count 
1  
 
 
2  
 
 
Day 9 Weight of tissue 
Isolate Colony count 
1  
 
 
2  
 
 
 ANTIBIOGRAM 
 
S.No Drugs A B C Remarks 
1.  Ampicillin     
2.  Amoxycillin     
3.  Amoxyclav     
4.  Linezolid     
5.  Erythromycin     
6.  Tobramycin     
7.  Cotimoxazole     
8.  Doxycycline     
9.  Amikacin     
10. Gentamicin     
11. Ciprofloxacin     
12. Ofloxacin     
13. Cephelexin     
14. Cefixime     
15. Cefotaxime     
16. Ceftrioxone     
17. Ceftazidime     
18. Ceftazidime+clav     
19. Cefipime     
20. Piperacillin+Tazo     
21. Aztreonam     
22. Imipenam     
23. Vancomycin     
 
MEDIA PREPARATION 
NUTRIENT AGAR: 
2.8 gm of dehydrated nutrient agar powder is taken and 100 ml of distill 
water is added. It was boiled to dissolve it completely. pH is adjusted to 7.4. 
Autoclaved at 121°C for 15 min and plated. 
MACCONKEY AGAR: 
5.5 gm dehydrated MacConkey agar is taken and 100 ml distill water is 
added. Then it is heated to dissolve completely. pH adjusted to 7.4. Then 
autoclaved at 121 ° C for 15 min. 
BLOOD AGAR: 
8 ml of human blood is added to the prepared nutrient agar. Mix thoroughly 
.then autoclaved at 121 ° C for 15 min and plated. 
MUELLER-HINTON AGAR: 
3.8 gm of dehydrated media is taken and 100 ml of distilled water is 
added. Then it is heated to dissolve completely. pH is adjusted to 7.3.Them 
autoclaved at 121° C for 15 min. Then plated. 
GRAM STAIN: 
Methyl violet: 
  Methyl violet – 1.5 gm  
Distilled water – 100 ml 
 
 
Grams iodine 
Potassium iodide – 2 gm 
Iodine  - 2 gm 
Water – 100 ml 
 
DILUTE CARBOL FUCHSCIN: 
Strong carbolfuchscin: 
Basic fuchscin – 0.5 gm  
Phenol crystal – 2.5 gm  
Alcohol – 10 ml 
 Water - 90 ml 
Take 1 ml of strong carbolfuchscin and add 19 ml of distill water. 
 
INDOLE TEST: 
Peptone water: 
Peptone  - 5gm 
Sodium chloride – 2.5 gm 
Water – 500 ml 
Autoclave at 121 ° C for 15 minutes 
 
METHYL RED TEST/VOGES PROSKAUER TEST: 
MR-VP broth : 
1.7 gm of glucose phosphate broth is taken and 100 ml distilled water is 
added and it heated to dissolve completely. pH adjusted to 6.9. Then autoclaved 
at 121 ° C for 15 min. Then dispensed in separate tubes. 
 
MR reagent: 
 Methyl red - 0.1 gm 
95 % Ethyl alcohol – 300 ml 
VP reagent 1: 
α- naphthol – 5 gm 
Absolute ethyl alcohol – 100 ml 
 
VP reagent 2: 
Potassium hydroxide – 40 gm 
Distilled water – 100 ml 
 
CITRATE UTILIZATION TEST 
2.428 gm of dehydrated citrate powder is taken in a conical flask and 100 
ml of distilled water is added. It was boiled till it dissolved completely. pH 
adjusted to 6.8. Then autoclaved at 121° C for 15 min. 
 
UREASE TEST: 
2.401 gm of dehydrated urea agar base is taken and 95 ml of distilled 
water is added. It was boiled to dissolve it completely. pH adjusted to 6.8. Then 
autoclaved at 121° C for 15 min and then cooled to 50° C. 5 ml of 40% of 
urease solution is added. 
TRIPLE SUGAR IRON AGAR: 
6.452 gm of dehydrated medium is taken and mixed with 100 ml of distill 
water. Then it is heated to dissolve. pH is adjusted to 7.4.Then autoclaved at 
121̊ C for 15 min. Then it is dispensed in test tubes in such a way to form a slant 
and butt. 
NITRATE REDUCTION TEST: 
Nitrate broth: 
0.9 gm of dehydrated medium is taken and mixed with 100 ml of distilled 
water. Heat to dissolve completely.pH is adjusted to 7. Then autoclave at     
121° C for 15 min. Then it is dispensed in test tubes. 
Nitrate reagent: 
α- Naphthylamine – 0.5 gm 
30% Acetic acid – 100 ml 
 
OF TEST: 
1.935 gm of dehydrated Hugh-Leifson’s OF medium is taken and 100 ml 
of distilled water is added and boiled it to dissolve completely. pH adjusted to 
6.8 and then dispensed in separate tubes. Autoclaved at 121° c for 15 min. 
LAO DECARBOXYLATION TEST: 
1.052 gm of dehydrated decarboxylase base is taken and 100 ml of 
distilled water is added. 10 gm of Lysine, arginine and ornithine are taken 
separately and is added and boiled to dissolve it completely. pH adjusted to 6. 
Dispensed in 5 ml amounts in separate tubes and then autoclaved. 
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